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5 Abstract 
Background 
The early identification of developmental disorders facilitates early intervention, improving childhood outcomes. 
Parent-administered questionnaires have been recommended for this purpose. The PEDS COMBINED, which 
includes the Parents Evaluation of Developmental Status (PEDS) and PEDS Developmental Milestones 
(PEDS:DM), and the Ages and Stages Questionnaire (ASQ) are parent-administered questionnaires with good 
psychometric properties. It has not been determined if they identify the same infants at-risk for developmental 
delays however. It is also not know how South African paediatricians monitor childhood development. 
Objective 
To compare the ASQ, PEDS COMBINED and South African paediatricians’ subjective assessment (PSA) of 
neonatal intensive care graduates at 6-months corrected age.  
To identify trends in developmental screening practices, including the knowledge and use of parent-
administered screening tools, in a diverse group of paediatricans working in Gauteng, South Africa. 
Methods 
Developmental screening and referral practices of paediatricians were ascertained by analysis of a short 
questionnaire sent to participating paediatricians. 
Concordance between the questionnaires and PSA was determined using the kappa coefficient (κ) and Test of 
Symmetry (κ ≤ 0.4 indicating poor agreement; κ ≥ 0.75 indicating excellent agreement).  
Results 
Concordance between the ASQ and PEDS COMBINED was 90.7% (κ = 0.82, ρ = 0.05). The PSA showed poor 
concordance with both PEDS COMBINED and ASQ (κ = 0.28, ρ = 0.03 and κ= 0.26, ρ = 0.01 respectively).  
The ASQ and PEDS COMBINED identified 40% and 42% of the cohort with developmental concerns and the 
PSA identified 6%. Only 13% of paediatricians used specific guidelines for developmental assessment and none 
used, or could name any parent-administered questionnaire.  
Conclusion 
There is excellent agreement between the ASQ and PEDS COMBINED in identifying the same children with 
developmental concerns. Paediatricians identified significantly fewer infants and showed statistically significant 
poor agreement with both questionnaires. Most paediatricians in Gauteng, South Africa are not using 
standardized screening tools to detect developmental delay and have poor knowledge regarding these tools.  
Key Words 
Developmental screening; Developmental delay; PEDS; PEDS:DM; PEDS COMBINED ;ASQ; NICU 
infant; paediatrician; South Africa. 
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10  Literature Review 
10.1 Outcomes of the At‐Risk Infant 
The immature nervous system is continuously influenced by an interaction between biology and the environment 
and as a result the developing infant is vulnerable to the negative impact of adverse experiences (1). These 
adverse influences can include social risk factors (such as poverty, lower parental education and maternal 
depression) as well as medical risk factors (such as premature birth, lung disease and post-natal infections). 
Infants who experience social or medical risk factors are called high-risk or at-risk infants as they are at greater 
risk for poor neurological, cognitive, social and behavioral outcomes than infants who do not experience these 
risk factors. Social and medical risk factors are individually responsible for adverse developmental outcomes, 
although they are interdependent with compounding effect. (1, 2, 3) This review concentrates on the medical 
risk factors experienced by infants requiring neonatal intensive care in the perinatal period that result in 
neurological impairment or dysfunction.  
 
Alyward  & Verhulst (4) describe a typical high-risk nursery as one containing primarily preterm 
infants as well as full-term infants who have experienced perinatal complications. The literature 
categorises infants in the neonatal intensive care unit (NICU) as either higher risk or lower risk 
(Table 1) depending on their gestational age, birth weight or primary morbidity. (5, 6)  
 
Table 1 Classification of Risk in NICU infants 
Classification Infants born… Description Abbreviation 
between 34 – 37 weeks 
gestation 
Late pre-term LPT 
after 37 weeks Full-term FT 
Lower risk 
weighing 1500g -  2500g Low-birth weight  LBW 
before 34 weeks gestation Very preterm VPT 
weighing less than 1000g. Extremely low-birth 
weight infants  
ELBW 
Higher risk 
weighing less than 1500g Very low birth-weight  VLBW 
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10.1.1 Significant Neurological Impairments 
The risk of serious neurological morbidities such as intraventricular haemorrhage and periventricular 
leucomalacia increases with decreasing gestational age and birth weight. They are a significant cause of 
cerebral palsy and other major neurodevelopmental impairments in the NICU infant. Chronic lung disease, 
infection and necrotizing enterocolitis are also known predictors of adverse neurological outcomes, along with 
male gender and exposure to postnatal steroids. (3, 7) 
 
Retinopathy of prematurity and cortical visual impairment are noted to be the most common causes of severe 
visual impairment and blindness in the preterm infant, with amblyopia and refractive errors also being common. 
The auditory system in the preterm infant can be affected by ototoxic drugs and NICU infants are therefore also 
at risk for conductive hearing loss and auditory neuropathies (8).  
 
In their review of extremely premature infants Robertson, Watt and Dinu (8) noted improved medical care had 
resulted in a decreasing incidence of these major neurological impairments over the past 30 years with the 
exception of intellectual impairment. The prevalence of cerebral palsy decreased from 77/1000 extremely 
preterm births in the 1990’s to as low as 19/1000 births by the early 2000’s. By the early 2000’s blindness and 
hearing loss as a result of premature birth had also decreased to less than 1% of survivors. 
 
Major neurological impairments are an important consideration in NICU infants but inline with their decreasing 
incidence, literature has started to look at more subtle outcomes of developmental delay in NICU infants such as 
learning disabilities, behavioral problems and quality of life (QoL). (9, 10, 11) 
 
10.1.2 Developmental Delay 
Normal development proceeds from basic skills to integrated functions involving higher cognitive process such 
as problem solving and planning. Initial skills are species specific and “prewired” into the neurological system 
resulting in easily identifiable milestones typically involved in early infant screening and assessment. These 
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milestones are divided into the domains of motor (gross and fine), language (expressive and receptive), 
personal-social (behavior, social, emotional) and adaptive (cognitive, problem solving) development. (12, 13)  
 
When an infant or child does not reach a milestone in one or more of these domains at the expected age (within 
the range of normal variation) they are described as developmentally delayed (14). Developmental delay is most 
often determined by a percentage (e.g. 20% delay), a standard deviation (SD) below the mean in a reference 
group (normally 2SD) or a comparison of milestones to the 50th percentile of population groups (12). 
Developmental delay normally refers to milder delays resulting in coordination difficulties, academic difficulties, 
behavioural problems or social-emotional disturbances negatively affecting the quality of life of the children and 
their families. Health related QoL measures take into account the World Health Organizations’ definition of 
health, which looks at an individual’s physical, mental and social well-being, rather than merely the absence of 
disease (15). 
 
10.1.2.1 The NICU infant 
The NICU infant has been shown to be at a greater risk for developmental delay and poorer health related QoL 
than infants born full term, regardless of their gestational age, birth-weight or diagnosis (10, 15, 16). Compared 
to full-term controls, pre-school aged children who required neonatal intensive care needed more help for 
activities of daily living such as eating, bathing, dressing and toileting. Even in children with no co-morbidities 
that required NICU care, difficulty getting around was four times greater and problems with learning and memory 
were three times greater than children who did not require NICU care (15). 
 
Lower-risk NICU infants are still significantly more likely to require early intervention or special education than 
infants born without medical risk (10, 17, 18). A large study looking at 7187 NICU infants who were lower-risk 
(due to a birth weight greater than 1500g) found that compared to full-term healthy infants, these infants were 
significantly more likely to have special health care needs (requiring medication, using more health services and 
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having an activity limitation). These infants were also significantly more likely to have a learning disability or 
Attention Disorder (6).  
 
NICU infants who are lower-risk due to their full-term status also show more difficulties with learning, memory 
and motor development compared to children who did not require intensive care at birth (19). Full-term NICU 
infants have been shown to deviate from full-term healthy children in motor performance and social interactions 
by their first year; and speech and linguistic skills by 6 ½ years. In a 10-year follow-up study of NICU infants, 
although 94% of NICU graduates were able to attend mainstream schooling, more than 40% required some sort 
of educational support such as speech therapy, a special education teacher or a special teaching group outside 
of the regular classroom. Children who were very preterm (VPT) were more likely to be a year behind their 
expected grade, require educational support or attend special educational facilities than the children that were 
late preterm (LPT) or full-term NICU graduates. (16, 20) 
 
Kalia et.al also found VPT infants required more intervention than LPT infants with 30% of LPT infants qualifying 
for enrollment in a physiotherapy, speech therapy or occupational therapy programme compared to 70% of VPT 
infants. After controlling for co-morbidities (which correlated inversely with gestational age) infants in either 
group were equally likely to qualify for intervention services however, indicating a significant risk for 
developmental difficulties in lower-risk NICU infants and highlighting the negative impact of co-morbidities (21).  
 
NICU infants of all gestational ages and birth-weights are clearly a population group at risk for developmental 
difficulties. The morbidities experienced in the newborn period are the most significant cause of developmental 
difficulties requiring Early Intervention (EI), rather than the degree of prematurity, however VPT babies are likely 
to have more problems and experience worse outcomes (21). Accordingly, most of the literature on outcomes of 
the NICU infant is concerned with the higher-risk NICU infant, those born at less than 34 weeks or weighing less 
than 1500g. The literature on this specific population group is therefore discussed in the following section. 
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10.1.2.2 The Higher Risk NICU Infant 
The “modern era” of neonatal intensive care beginning in the 1960’s has resulted in increasing survival of low 
birth weight (LBW) and extremely low birth weight (ELBW) infants with significant reductions in major 
morbidities. Outcomes of ELBW infants from the EPICure study show that although developmental disabilities 
were present in at least half of all survivors, only a quarter of these met the criteria for severe disability (22). 
Along with the World Health Organization’s International Classification of Function for Children and Youths (ICF-
CY) and increasing interest in QoL, research on these high risk premature infants has shifted from identifying 
the disability towards identifying the more subtle developmental delays with their long-term implications for 
activity limitations and participation in the context of the individual and society. (23, 24, 25) 
 
Studies following very low-birth-weight (VLBW) infants into adolescence show higher rates of 
neurodevelopmental disabilities compared to their full-term peers, despite normal intelligence. This results in 
poorer academic and social functioning and higher educational needs (26). Clinically, preterm infants show 
significantly lower reading, mathematics and spelling scores than their full-term peers (9). In addition studies 
following these infants into adulthood show similar trends of lower levels of academic achievement and lower 
salaries, increasing the burden of support on tax payers and society as a whole. (27, 28) These long-term 
outcomes of preterm infants are found cross-culturally and within many different countries (9). 
 
Some studies of QoL and outcomes in teenagers and adults who were born VPT or VLBW have shown these 
infants achieve similar educational attainment, socioeconomic status and marital status compared to their full-
term peers. Parents of these teenagers and adults often noted significantly poorer performance in global health, 
behaviour and physical functioning however; with more cognitive, mobility and self-care limitations. It is therefore 
important when looking at the QoL and long-term outcomes of VPT or VLBW adults to also look at the therapy 
they received in their early years, as well as their specific schooling requirements or schooling patterns. This 
may assist in a better understanding of the interventions needed to achieve more positive outcomes for these 
higher risk infants. (11, 29, 30) 
 17 
Reuner, Hassenpflug and Pietz (10) attributed the positive outcomes seen in their LBW population at 17 years 
of age to the fact that their study group was from a tertiary neonatal centre where preterm infants received an 
intensive follow-up and early intervention (EI) programme. Even though outcomes were positive, the LBW 
children in their study tended to start school later than their full-term peers, with a trend towards lower school 
graduation. Therapeutic intervention such as occupational therapy, speech therapy and physiotherapy was 
required by 72% of the LBW children, compared to 51% of their full term peers and LBW children often required 
two or even three different interventions. Similarly, in an outcome study of 12-year-old children born 
prematurely, 76% with a diagnosed brain injury and 35% without a diagnosed brain injury at birth needed an 
Individualized Education Plan (IEP) compared to 10% of children born at full-term (26). These studies show how 
the pathway to more positive outcomes in preterm children may differ significantly from their full-term peers, with 
an increased need for therapeutic intervention and delayed school enrollment placing a greater burden on 
preterm children and their families.  
 
A recent meta-analysis by Aarnoudse-Moens, Weisglas-Kuperus and van Goudoever (9) in August 2009 
suggest that the disadvantage in academic achievement, behaviour and neurocognitive function persists into 
young adulthood (22.3 years of age) for very preterm and very low birth weight (VLBW) infants and highlights 
the need to focus on early intervention strategies to achieve more positive outcomes.  
 
10.2 Early Intervention 
Early Intervention is described as a multidisciplinary approach to enhance emerging abilities and prevent delays 
in children from birth to 5 years of age. It includes the remediation of existing or emerging disabilities and the 
prevention of functional deterioration. Adaptive parenting and overall family function is an important aspect of EI, 
as is promoting the child’s health and wellbeing. EI occurs through individualized developmental, educational 
and therapeutic services using techniques derived from the disciplines of physiotherapy, occupational therapy, 
developmental psychology and education (31). 
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There is considerable empirical evidence that various types of EI promote child development, reduce gaps in 
school readiness, and improve outcomes in later life. Learning and skill formation build on previous learning, 
therefore school readiness is critical for academic achievement. A child’s health status and academic 
achievement are co-dependent outcomes of EI. Less education is associated with a shorter life span, earlier 
onset of chronic disease or disability and increased risk of poor health related behaviors such as smoking, 
teenage pregnancies and crime; whilst poor health may be associated with lower academic achievement. (32, 
33, 34) 
 
Neural plasticity and the neuronal group selection theories (NGST) can be used to motivate for intervention to 
be started as early as possible. Neural plasticity refers to change in function of existing neurons and synapses in 
the brain and is most active in the first 8 months of life. NGST is the reprogramming and reorganizing of neural 
tissue and their networks into functional units through variable experiences and repetition. Before 3 years of 
age, NGST suggests that intervention through variable experiences could increase the primary repertoire of 
neuronal networks and enhance selectivity. In the older child, networks are already established and intervention 
will be less effective in changing them. Neural plasticity and neuronal group selection can result in both negative 
and positive adaptive behavior depending on the experience of the infant. EI is therefore important not only in 
remediating difficulties, but in preventing deviant development. (35) 
 
The Dynamic Systems Theory of development looks at development in relation to the interaction of multiple 
subsystems within the child and the environment. Systems within the child such as muscle strength and 
motivation interact and are changed by systems within the environment such as experience and the demand of 
a task (35, 36). The Dynamic Systems Theory supports EI by acknowledging that small, critical changes in one 
subsystem (such improving trunk control) can result in large changes in developmental abilities (such as 
improved ability to play) (37). 
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In the context of neural plasticity, NGST and the Dynamic Systems Approach, EI should be most effective when 
started as early as possible. This is supported by studies that have shown improved effect of intervention started 
earlier, with some interventions aiming to start before 6 months of age. (38, 39, 47) 
 
When intervention is begun early it is more effective than remediation in addressing developmental delay, as the 
rate of learning for remediation must exceed the rate of learning of those children who are performing on age-
level. Children who are delayed must not only “catch-up” to their peers, but also “keep-up” with them as they 
learn new learn skills. This highlights the importance of EI in ensuring children start school with developmentally 
appropriate skills (32).  
 
The development of competence is highly related to the development of emotional regulation, social skills and 
intelligence. Lack of competence creates negative experiences with far reaching impact for those children who 
are not assisted in developing skills for which they have difficulty.  The provision of high-quality EI with 
appropriately skilled staff can produce short-term gains in individual development as well as long-term human 
capital gains. Investing in effective services that promote child development well before the start of school and 
facilitate full access to early intervention is therefore optimal (1, 40). 
 
10.2.1 Effectiveness of Early Intervention 
The effectiveness of intervention generally is supported by studies which look at specific goals in children such 
as an occupational therapy programme to improve upper limb function (41), speech therapy to address 
language delay (42) or gross motor programmes to improve physical activity and proficiency (43). 
  
The effectiveness of EI in at-risk infants is supported by a substantial amount of literature. Cochrane reviews 
and meta-analyses have looked at intervention programmes for prematurely born infants that begin before the 
first 12 months of life (44, 45). The literature shows a significantly positive effect for this type of early 
intervention, particularly when the parent-child relationship is emphasized. Interventions addressing both the 
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parent-child interaction, as well as the child’s specific developmental issues were more effective than 
programmes that addressed only one of these components. A higher level of intensity or duration of early 
intervention programmes also resulted in more sustained positive effects and better outcomes. Other positive 
factors contributing to the success of early intervention were the early start of the programme, professionally 
trained staff and adequate staff-child ratios. (1, 32) 
 
One of the largest and most comprehensive EI studies cited in the systematic reviews on the long-term benefits 
of EI is the Infant Health and Development Program (IHDP). Since so many studies examining the effect of EI 
for premature infants from infancy to 18 years of age are based on this programme (45), it is described in the 
following section in more detail.  
 
10.2.1.1 IHDP 
IHDP was a multi-centre EI programme for low birth weight, premature infants, with long-term follow up. The 
Promising Practices Network (46) described the IHDP study as using rigorous standards, including a 
randomized experimental design and longitudinal follow-up. McCormick, Brooks-Gunn and Buka (33) published 
the 18 year outcomes of this study and highlighted the fact that whereas most studies that document the 
educational and social benefits of early intervention programmes focus on lower socioeconomic groups, this 
study looked at a group of low birth weight infants who were otherwise heterogeneous for socioeconomic and 
health status. The intervention programme consisted of 3 parts: home visits by a professional to implement a 
general developmental programme and target specific difficulties identified; a centre-based education 
programme for infants from 12 months to 36 months (5 days/week for 4 hours each day) and a bimonthly parent 
support group. It is important to note that infants in the control group who did not receive these services did 
receive standard care including referral to community services when indicated.  
 
In the total intervention group, there were no statistically significant differences in outcome at age 18 years 
compared to the control group, however, when the intervention group was stratified into infants with a birth 
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weight of < 2000g i.e. low low-birth-weight (LLBW) and those with a birth weight of >2000g i.e. high low-birth-
weight (HLBW), statistically significant differences were found in the HLBW group who received intervention 
compared to the HLBW group who did not receive intervention. Higher IQ scores, better maths and reading 
scores and fewer risky behaviours were found in the intervention group compared to the controls. There was 
also a trend towards fewer of the intervention group being classified as needing special education (17% vs 
24%). (47) This highlights not only the benefits of EI, but also the importance of identifying and defining specific 
variables when assessing outcomes of early intervention programmes  
 
Stratifying the groups based on the amount and intensity of therapy services therefore may have resulted in 
statistically different outcomes as it did when groups were stratified by birth-weight. In looking at the poor effect 
of EI for the LLBW group, the authors did not account for the fact that most of the infants in the intervention and 
control groups were likely to have received EI as standard care (10, 16). Kalia, Visintainer and Brumberg (21) 
reported 70% of VPT, compared to 30% of LPT infants required enrollment in speech, physiotherapy or 
occupational therapy. The percentage of infants from the IHDP study receiving EI in the LLBW groups may have 
been similar. This could therefore have accounted for similar outcomes in the intervention and control groups, 
as both groups received standard follow-up care.  
 
The influence of intensity of intervention on outcomes can be seen in the IHDP study where infants who 
attended >400 hours of the EI programme (out of the 500 hours in total) scored higher on IQ tests and did not 
show an attenuation of EI benefits with age (33). Reuner et.al. also noted that intensive follow-up and 
intervention received by the infants in their follow-up study of low birth-weight infants may have been the reason 
for the low prevalence of cognitive deficits found in their cohort (10).  
 
A four-point difference in favour of the intervention group on the Peabody Picture Vocabulary test (PPV-III) a 
measure of scholastic aptitude - remained stable from 8 to 18 years showing the potential of early intervention to 
lower the percentage of children who do poorly at school. The authors (33) stated that although true long-term 
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economic benefits could only be identified when the subjects reached 27 – 40 years of age, the current phase of 
the IHDP study supported the benefits of early intervention for long-term outcomes. 
 
Fiscella and Kitzman (32) concluded their report on the disparities of academic achievement and health by 
recommending that closing gaps in children’s academic achievements will require the funding of early child and 
family intervention programs. In 2008 the cost of EI for pre-term infants was reported to be $611 million a year 
and special education $1.1 billion a year, with the annual economic burden being $26.2 billion (30). It is 
therefore essential that the benefits of EI be scientifically documented and services for this at-risk population 
group optimized to ensure best possible outcomes. Infants and families that participated in the IHDP programme 
have shown quantifiable benefits thus offering excellent scientific evidence for the effectiveness of EI.  
 
Regarding the IHDP, 
 “It is very significant that early intervention can still make a measurable difference in such a 
diverse group of children after 18 years” (48)  
 
10.2.2 Issues in Early Intervention  
The practice of developmental-behavioral medicine and the implementation of early intervention are 
encapsulated in the statement from the collaborative scientific report ‘From Neurons to Neighborhoods’, 
“the course of development can be altered in early childhood by effective interventions that 
change the balance between risk and protection, thereby shifting the odds in favor of more 
adaptive outcomes.” (1)  
 
EI is expensive and labour intensive however. Not all infants need it, but those that do need it earlier rather than 
later. It is therefore important not only to identify which interventions are truly effective in improving the long-term 
outcomes of this vulnerable population, but which infants would in fact benefit from the different interventions. 
(10, 45, 49) 
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Reviews and meta-analyses on the effectiveness of EI find the diversity of assessment tools, length of follow-
ups, as well as the heterogeneity of treatments (time of initiation, duration, intensity and type of professional 
leading the programme) limit the ability to compare results between studies effectively. (44, 45, 48) 
 
There are also a number of important issues to consider when reviewing literature on EI. Firstly careful selection 
of cohorts and outcome measures are essential when assessing the benefit or effect of EI. Secondly, an 
understanding not only of the great variability of normal development, but of the interplay and interdependency 
between the different developmental domains is critical, particularly in the younger infant. Thirdly, the effect of 
intervening variables on these developmental domains such as socioeconomic status (SES) and medical risk 
factors cannot be ignored as they strongly influence infant outcomes.  
 
10.2.2.1 Intervening variables 
Intervening variables confound research into the long-term outcomes of EI. The developing child remains 
vulnerable throughout the early years and even into adulthood so that early benefits can be negated by negative 
experiences or enhanced by positive ones (1).  
 
The effect of experiences can be shown in long-term follow-up studies where it has been found that the positive 
effects seen in children who received EI attenuates with age. There is less of an advantage in the older child 
and young adult who received EI compared to those who didn’t. This decreasing advantage may be explained 
by the fact that in many of the long-term outcome studies, although “control” group children did not receive 
specific EI treatment they received therapy or assistance in line with normal protocols. This potentially 
influenced the long-term outcomes of the control group and may have been a reason for their “catching-up” with 
the intervention group (10). On the other hand variables such as disadvantaged economic backgrounds can 
negatively influence development. For example, performance by school-age in the domain of fine motor 
 24 
development has been shown to be particularly influenced lower SES and lower birth weight, resulting in worse 
outcomes for these children (50).  
 
10.2.2.2 Selection of Cohorts 
EI can mean intervention that occurs early in life or intervention that occurs early in the expression of a 
morbidity. Most studies looking at the benefits of early intervention focus on infants at risk for developmental 
difficulties. At these early stages, developmental difficulties are not readily apparent and intervention services 
are therefore often targeted at children who may not need or benefit from them. These EI programmes can be 
classified predominantly as “prevention programmes” since specific problems that require “treatment” are not yet 
identifiable. This results in studies not assessing the true benefit of early intervention in the infant and child with 
actual developmental delay (44). On the other hand, once a developmental delay or disability is recognized it 
would be unethical to withhold treatment, making it difficult to assess the true benefit of intervention and the 
effects of intervention applied earlier rather than later in an identified condition.  
 
10.2.2.3 Assessment Times and Tools 
Spittle, Orton & Doyle (44) questioned how the reliability and validity of the assessment tools at different ages 
influenced results. For example, two of the studies assessed in their review which had shown no difference 
between the treatment and control group at one year, showed a significant difference in favor of the treatment 
group at two years.  
 
The possibility of selecting the incorrect tools to detect change was pointed out by Rosenbaum when describing 
their study of gross motor development in pre-school children with Down Syndrome. In this study, although the 
Bayley Scales of Infant and Toddler Development – II (BSID-II) was able to discriminate the motor function of 
children based on age, it was unable to pick up change over a 6-month period. In the same population group 
however, the GMFM (Gross Motor Function Measure) was able to show graded changes over the same time 
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period, illustrating the limitations of well-developed and validated measures when they are used for purposes 
other than what they were designed for (51).  
 
10.2.2.4 Developmental Domains and Outcomes 
Understanding the relationship between early developmental delays and long term outcomes is also vital to the 
effective analysis of EI programmes. Some studies have shown a poor correlation between early difficulties and 
later outcomes in a specific domain. As an example there may be little significant difference in motor outcomes 
in the older child who had motor delays in infancy compared to the normal population. (52, 53) Piek, Dawson, 
Smith and Gasson (50) assessed developmental trajectories in infants across several developmental domains 
using parent-administered questionnaires. They found that although the infant’s gross and fine motor 
performance was not predictive of school-age performance in gross and fine motor domains, there was a 
significant relationship between early gross motor performance and school-aged academic performance.  
 
Other studies have supported this link between gross motor performance in the infant and cognitive outcomes in 
later years (54). In their cohort of low-risk infants (mean gestational age = 37 weeks), Piek et.al. (50) found 
motor development was significantly predictive of school age cognitive performance, specifically working 
memory and processing speed, regardless of gestational age or socioeconomic status (SES). In contrast there 
was no correlation between the infant’s cognitive function (problem-solving and personal-social skills) and later 
intelligence tests at school-age.  
 
10.2.2.5 Variations in normal development 
A unique aspect of the study by Piek et.al. (50) was the ability to assess development at several time points 
(each child underwent 11 separate assessments by their fourth year), creating an early developmental 
trajectory, rather than a once-off assessment of development for each child.  This accounted for the increasing 
evidence of intra-individual and inter-individual variation of infant development as shown in a study of toddlers 
who were all assessed as normal at 18 months. Prior to their 18-month assessment 31% had fallen below the 
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10th percentile in at least one developmental assessment (55). Typical development is not linear and does not 
occur at a consistent rate. This makes it difficult to distinguish normal from delayed and transient disorders from 
persistent impairments (1) and highlights the need for the assessment of development to include multiple 
domains and be repeated at multiple time points  (55, 56). 
 
To assess a group of infants for research or intervention purposes at frequent intervals is prohibitive in terms of 
costs, time and the level of expertise required, as experienced clinicians are essential in performing 
developmental assessments of acceptable quality (12, 57). Piek et.al (50) clearly demonstrated that using 
parent-administered screening tools can be effective in research and assessment and therefore may be used to 
overcome some of these barriers. Use of parent-administered screening tools in screening for developmental 
delay has been frequently recommended for use in identifying children with possible disordered development for 
both clinical and research purposes. (57, 58) 
 
10.3 Screening for Developmental Delay 
Early identification of developmental delay is critical for the effective implementation of early intervention (EI). 
The earlier intervention is begun, the more effective it can be in remediating or even preventing the negative 
sequelae which result from developmental difficulties. (39, 47, 59) 
 
The early detection of developmental delay is not straight forward and has been decribed as trying to measure a 
moving target, with a wide variance in the timing of skills emerging, or the possiblity of skills being latent (not yet 
measurable), delayed, deficient, or disordered at any one point in time (49). The wide variability in normal 
development makes subjective assessments unreliable and studies have shown improvements in accuracy and 
a decrease in missed early diagnosis with the use of standardised tools. (47, 60, 61) 
 
In a 2006 policy statement on identifying infants and young children with developmental disorders, the American 
Academy of Pediatrics (AAP) stated that the early identification of developmental disorders is the responsibility 
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of all paediatric health care professionals (58). The AAP recommend using surveillance and screening 
processes to identify those children who would benefit from an assessment or evaluation. Surveillance is 
described as the process of identifying children who may be at risk of developmental difficulties through a 
continuous and longitudinal relationship with the family and child, whilst screening is described as the use of 
validated tools to identify and define that risk. An assessment or evaluation is described as a complex process 
aimed at identifying a specific developmental disorder and involves the use of tools that are expensive, time 
intensive and require a high level of expertise and experience from the administrator.  
 
A screening tool does not result in either a diagnosis or a treatment plan but rather identifies areas in which a 
child’s development differs from the same-age norms. Screening tools are quick to administer and can often be 
completed by the parent or caregiver. The AAP recommends developmental screening using high quality 
standardised tools as part of the usual practice of well-baby care for all infants and children regardless of their 
risk status and even if they appear to be developing normally. Tools should be used at regular intervals or 
whenever there are any concerns raised by the parent, health professionals or others involved in the care of the 
child. They recommend repeated and regular screening to account for the dynamic nature of development and 
the inherent limits of screening tools. They caution that waiting until a child misses a major milestone before 
initiating evaluation processes will deprive the family of the benefits of early identification and early intervention. 
Failure to detect difficulties early results in missed opportunities to address problems before they become more 
limiting and costly to treat. Problems which may have been easily remediated with EI may require much more 
extensive intervention later in life, with the possibility of less optimal outcomes. (58, 62, 63, 64) 
 
One argument against the use of ongoing developmental screening is presented by Johnson & Marlow (65). 
The authors argue that in premature infants the initial screening stage is redundant because abnormalities 
shown by premature infants within the first two years of life are variable and transient, whilst some disabilities 
such as cerebral palsy only become apparent around two years of age. They state that because prematurity is 
such a ‘clear medical risk factor’ for developmental delay, it is preferable for all children born prematurely to 
rather have a hands-on, in-depth developmental assessment at 2 years of age. The problem with this approach 
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is three-fold. Firstly, many children are lost to follow-up and may miss the 2-year assessment, only to re-emerge 
at school age when EI is too late (17, 62). Secondly, enrollment of infants in EI programmes before the end of 
the first year is possible and has been shown in many studies to be a realistic goal for optimizing intervention 
(10, 32, 45, 47, 66). Waiting 2 years before identifying children with difficulties is not conducive to EI which aims 
to start as early as possible in order to maximize the benefits of neural plasticity and neuronal network selection 
(35). Thirdly, most children with severe or clinically evident delays such as cerebral palsy are identified earlier, 
but more subtle impairments are difficult to identify, highlighting the need for ongoing and regular screening (2, 
67, 68). Even though prematurity is a higher risk for developmental delay, developmental problems in premature 
babies are not always identified earlier than in full term babies, but earlier recognition of problems is associated 
with earlier referral to rehabilitation services. The use of early systematic developmental screening to aid early 
identification and early referral is therefore recommended (17, 69). 
 
The value of these recommendations was recently shown in 2007 by van Agt, et al. (38) in a cluster-randomized 
control trial of 5406 children. In this study children were followed up at eight years of age to assess differences 
in educational needs and academic function between those who had undergone systematic developmental 
screening and those who had had normal paediatric care. More than fifty physicians were randomly assigned to 
control or intervention groups. Physicians in the intervention group were trained in EI screening methods for 
language delays, whilst physicians in the control group provided normal care which involved physician’s 
observations and parent questioning, without standardised methods of assessment or clear-cut referral criteria. 
Children were seen by either the ‘control group’ or ‘intervention group’ physician before 2 years of age and 
followed up at 8 years of age with a variety of assessments.  Low and high SES status between the groups was 
similar as was the number of children lost to follow-up. The study found that significantly more children in the 
intervention group received treatment and support before the age of 5 years than in the control group (ρ = 
0.024). By 8 years of age the number of children in either group receiving therapy was no longer statistically 
significant however the difference in the number of children with special education requirements and linguistic 
difficulties was statistically significant between the two groups. The intervention group showed a 30% reduction 
in the number of children attending special education and a 33% reduction in children with spelling difficulties, 
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emphasizing the positive benefits of starting intervention earlier. This study clearly shows how implementing 
standardised screening can improve the timing of early referrals to enhance the benefit of EI in children with 
developmental difficulties. 
  
Rydz, Shevell, Majnemer and Oskoui (13) justified screening for developmental delay within the guidelines from 
the World Health Organization on “Principles of Screening for Disease”. These include showing that 
developmental disability carries an appreciable burden to the individual, the family and society; that there is 
suitable testing available and acceptable treatment for patients with the condition; and the costs of case-finding 
and treatment is balanced by the benefits to the individual and society. 
 
An added benefit of implementing standardized developmental screening was found in a study that showed 
parents whose children received a developmental assessment were more likely to be aware of issues related to 
development. This included knowledge of developmental milestones such as first steps, first words or toilet 
training as well as the impact of the family and community on development. Examples of this include better 
knowledge about nutrition and health, discipline, smoking and substance abuse, parental support and spousal 
support. The parents were more likely to report being satisfied with the medical care their child received and 
their children were more likely to have access to developmental services (70).  
 
10.3.1 Properties of Screening Tools 
The AAP recommends that screening tools should address the different developmental domains including gross 
motor, fine motor, language and social-emotional development, as well as adaptive skills. Screening tools 
should be reliable and valid with sensitivity and specificity of 70% - 80%.  The AAP recommendations note that it 
is acceptable for screening tool values to be lower than other medical screening tests because of the challenges 
inherent in measuring child development (58). Screening tools must be brief with proven predictive value. They 
must have been standardised within the last 10 years and validated against other high quality diagnostic tests 
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with proven reliability including test-retest, inter-rater and internal consistency. They must also included clear 
criteria for passing or failing and guidance on what to do with the results. (49, 71).  
 
Screening tests are considered successful when they accurately identify the presence or absence of disease in 
a population group. Formal terminology around this concept has been summarized in Table 2 (13). 
 
Table 2 Testing Terminology 
Terminology Definition Referral for treatment 
True-positive Test correctly identifies someone with 
the disease 
Appropriate 
False-positive Tests incorrectly identifies someone 
with the disease 
Over-referral 
True-negative Test correctly identifies someone 
without the disease 
Appropriate 
False-negative Tests incorrectly identifies someone 
without the disease 
Under-referral 
Sensitivity 
The proportion of people with the 
disease whom the test will correctly 
identify 
High sensitivity  appropriate  
Low sensitivity  under-referral 
Specificity 
The proportion of people without the 
disease whom the test will correctly 
identify 
High specificity  appropriate  
Low Specificity  over-referral 
Reliability 
The stability of the screening tool when it is repeated under identical conditions. 
Variance in score results is due to true variance in those tested. 
Includes: interrater reliability, intrarater reliability, test-re-test reliability, internal 
consistency 
Validity 
The extent to which an assessment measures what it is actually supposed to 
measure. Includes: content validity, construct validity, criterion validity (concurrent 
and predictive) 
 
A test that has not been compared to “true” diagnostic states should not be labeled with sensitivity or specificity 
claims. Aylward (12) therefore cautions against the use of sensitivity and specificity terminology, arguing that 
there is no real “gold standard” in developmental evaluation and suggests the terms ‘copositivity’ and 
‘conegativity’ may be more accurate. Copositivity refers to the extent to which two tests agree that a patient has 
a condition, whilst conegativity is the extent to which the test agree on dismissing those patients without a 
condition. They are tests of reliability, not validity, because both tests could be wrong, but still correlate highly. 
Developmental tests also need to be constantly updated to keep up with new knowledge and to accommodate 
the Flynn effect, making newer tests (including the BSID-II) less well validated. The Flynn effect is the rise of the 
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average IQ test scores over generations (IQ gains over time). It is an effect seen in most parts of the world, 
although at varying rates. ‘Copositivity’ and ‘conegativity’ are therefore more accurate, but not used frequently in 
the literature however and sensitivity and specificity are still the most frequently used terminology. To account 
for the fact that there is no true standard reference or ‘gold standard’ in developmental testing, screening tests 
should therefore also be compared to a battery of tests that take functional outcomes into consideration such as 
school performance, in-grade retention and enrollment in special services. 
  
Although limitations of screening tools can lead to misclassification of a child’s developmental status (false 
positives and false negatives), the goal of developmental screening is to detect children who need further 
evaluation, not to diagnose developmental delays or disorders. Children with false positive screens will be 
identified as age-appropriate in the next stage evaluation, avoiding over-burdening intervention services, whilst 
ensuring that most children who do require early intervention are in fact identified early (49).  
 
Further, there is evidence that children with a false positive screen (those who fail screening but are not found to 
have a clinically significant delay on further assessment) are at greater risk for scoring in the lower ranges of 
normal than those who pass initial screening, provided the screening test used has good psychometric 
properties. Glasocoe (72) found that 70% of children with false-positive screening results scored below the 25th  
percentile (the cut-off used for placement in remedial reading and mathematics programmes) on one or more 
diagnostic measures of adaptive behavior, intelligence or academic achievement. Therefore, although this group 
of children do not need special education, they are a high-risk group for under achievement and poor school 
performance and benefit from closer monitoring and early stimulation programmes. This indicates that over-
referrals are not really a negative characteristic of developmental screening, but rather provide a beneficial 
service to highlight a group of children who may benefit substantially from further educational support.  This is 
especially important in light of the fact that those children with more subtle problems are more likely to have a 
significantly positive response to treatment, but are less likely than those with more serious conditions to be 
identified early (73). 
 
 32 
10.3.2 Paediatricians and Developmental Screening 
The AAP document (58) states that although undetected or untreated disordered development in early 
childhood can contribute to early school failure and attendant social and emotional problems, detection of 
developmental delay before school age is significantly lower than the prevalence of these delays. Only about 
30% of children who would benefit from early intervention are detected before school age (74). 
 
Paediatricians play a crucial role in identifying infants with developmental delay. They have an accepted role of 
authority and are in regular contact with the child from birth. Children are more likely to see a paediatrician than 
any other professional before school age and parents have been shown to take their recommendations 
seriously. Paediatricians are ideally situated to implement developmental screening and identify developmental 
delay in time for effective referrals to early intervention services. (13, 68)  
 
In the 2006 report, the AAP identified developmental screening as an area of paediatric care that is critical to the 
well-being of children and their families and the responsibility of all pediatric health care professionals. They 
found very few paediatricians were using effective means to screen their patients however (58). Most physicians 
in the USA were committed to the early diagnosis of developmental delay. Barriers of time and poor 
reimbursement as well as under-reliance on parent-administered questionnaires were identified as areas to be 
addressed (75). This is not unique to the USA and similar rates of under detection with poor reliance on parent-
administered questionnaires were reported in other first world countries including England, Australia, Canada 
and Ireland. (64, 76,77) 
 
In a literature review on developmental screening it was reported that most physicians use developmental 
milestone lists and informal checklists rather than standardized screening tools (73). Using milestones and 
checklists are an ineffective means of detecting developmental delay. They often fail to include tasks that are 
strong predictors of delays and disabilities or school success.  Many are based on studies that are outdated or 
based on limited sample sizes with a lack of population diversity. Most milestone checklists estimate the 50th 
percentile of population groups and do not effectively represent the large variability of normal development. It is 
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more useful to present information on the “typical range” of skill acquisition, or preferably, the mean age and 
standard deviation. This is especially true when the information is based on recent, large, diverse cohorts and 
linked to clinical problem solving strategies based on scientific research, as can be found in more modern and 
standardized screening tools. (61, 71) 
 
Barriers to the use of screening tools for paediatricians include insufficient time to implement them and 
insufficient reimbursement for time spent using them; Unfamiliarity with screening tools, inadequate office 
structures or under-skilled support staff also impede their use. The lack of available services to refer children 
identified with risks, or a lack of knowledge around these resources is also a reason cited for not using 
screening tools (75, 78). Financial barriers to developmental screening were recognized in an economic analysis 
of developmental detection methods in 1997. This report concluded that it may not be in the best financial 
interests of physicians to perform developmental screening as although it is in the best financial interest of 
society to identify and treat children with delays, the financial burden is borne primarily by the paediatrician (79).  
 
In a postal survey of paediatricians and general practitioners in America by Sices, Feudtner, McLaughlin and 
Drotar (75), only about half of physicians reported using a validated screening instrument and less than 15% 
used parent-completed questionnaires. Validated parent questionnaires address many of the barriers cited by 
paediatricians for not using screening tools. They are cost-effective, simple to use and reduce the amount of 
provider time needed for developmental screening (78). 
 
The success of implementing developmental screening in physicians’ offices using parent-administered 
questionnaires was documented in North Carolina. In 1999 only 2.6% of children between 0 – 3 years of age in 
North Carolina were receiving early intervention services despite the fact that an estimated 8% - 13% would 
have qualified and benefited from EI. The ABCD programme (Assuring Better Child Health and Development) 
was implemented statewide in physician practices to promote screening of all children using parent-
administered questionnaires. The number of well-child visits incorporating developmental screens increased 
from 15% in the year 2000 to 80% by the year 2008. As a result, between years 2004 and 2008, referrals to EI 
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programmes quadrupled, resulting in fewer North Carolina children entering school with unrecognized or 
untreated developmental problems (62). 
 
10.3.3 Parents and Developmental Screening 
A 2005  study (69) found that physicians were more likely to be the first to identify concerns in prematurely born 
infants, but parents were more likely to be the first to identify concerns in full-term infants. Neither the severity of 
the delay or the SES of the parents was associated with who first identified concerns in the infant’s 
development. Infants who were initially identified by physicians were likely to receive EI earlier than those first 
identified by their parents however. This implies that parent’s concerns were not given adequate recognition, an 
assumption supported in a study conducted by Sices et.al (75). In their survey less than 15% of 800 
paediatricians and family physicians agreed that parental concern was a good substitute for developmental 
screening. In another study parental concern was also not associated with any increased probability of referral 
to diagnostic or intervention services  (80).  
 
The ability of parents from differing economic and social backgrounds to accurately identify developmental 
difficulties in their infants has been established in the literature (69, 81), and has supported the development of 
screening tools using parent-administered questionnaires to elicit parental concerns and quantify their 
observations.  
 
10.4 Parent‐Administered Questionnaires 
When systematically elicited, parental concerns can identify children with developmental delays with a specificity 
and sensitivity approaching those of physician administered screening tests (81, 82, 83, 84). Using parent-
completed questionnaires involves parents in the process of child health supervision. This makes them partners 
early on in the process and consequently enhances early intervention, which is most effective when the parent-
child relationship is emphasized. (1, 32, 47) 
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Using parent-completed questionnaires also offers substantial monetary and time-savings over other screening 
methods (68). The use of validated and standardised parent-administered questionnaires was recommended by 
Rosenbaum, Missiuna, Knox and Echeverria (57) as recently as 2009. The authors described parent 
questionnaires as an appropriate and cost effective method for identifying children who require more detailed 
assessments in large-scale epidemiological studies. According to Ronsenbaum et al., parent-administered 
questionnaires are able to address both quantitative aspects of development, through questions about specific 
milestone acquisitions, and qualitative aspects, which can be elicited through unambiguous open-ended 
questions.  
 
Although parent-reported screening tests have many advantages, problems may arise when they are used in 
populations with limited literacy. Caregivers may respond randomly to questions, omit answers or not be able to 
use the questionnaires. These problems are easily overcome by offering assistance with filling out the 
questionnaire or performing the screen as an oral interview (13). 
 
Two of the most frequently cited and recommended parent-administered questionnaires used for developmental 
screening purposes are the Ages and Stages Questionnaire (ASQ) and the Parents Evaluation of 
Developmental Status (PEDS) (56, 58, 62, 85, 86).  
 
10.4.1 ASQ 
The ASQ is a child monitoring system designed to be completed by the infant or child’s primary caregiver in their 
home or in a clinic or community setting. It is primarily a milestone based checklist that has been standardized 
and overall has high levels of validity (0.86 to 0.91), reliability (interrater > 0.85, test–retest > 0.90), sensitivity 
(71.88%) and specificity (85.84%). (76, 87, 88)  
 
The ASQ has been used for developmental monitoring in epidemiological studies (89, 90) and follow-up of 
premature infants and paediatric patients with various medical conditions or developmental risks (91, 92, 93, 94, 
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95, 96, 97, 98). It has also been used in state-wide child development projects such as the Assuring Better Child 
Health and Development (ABCD) project (99). The ASQ has also been shown to be effective in identifying 
developmental information that can predict specific school-age outcomes (50). 
 
The ASQ is validated and is widely used in preventative health care in the USA and Canada. It has been used in 
studies from both first world and developing countries, including South Africa (76, 88, 89).  It has been 
translated into at least 6 other languages, with additional validation studies being done in Norway, Korea and 
Holland where it has shown good psychometric properties (100). 
 
The effectiveness and the cost of the ASQ in paediatric clinical practices was examined in a large study, 
consisting of 1428 parents or legal gaurdians and their infants aged 12, 24 or 30 months (17, 101). In this study 
parents or caregivers completed the ASQ when they arrived for their well-baby visit. Paediatricians were blinded 
as to the result of the questionnaire and followed usual assessment and referral procedures. It was found that 
the training required to implement the ASQ in the office setting took less than 30 minutes. It took less than 30 
seconds for office staff to give instructions to the person completing the form and approximatley 4 minutes for 
the office staff to score the ASQ, enter results in the medical records and complete recommended referrals. The 
cost of the implementing the screen was less than $2.50 per patient in 2005.  
 
A follow-up study in 2009 examined the long-term effects of implementing the ASQ (17, 101). After 
implementing the screen, referral rates to EI services increased by 224% with the greatest increase being in the 
12 month old age group. The number of children who actually became eligible for EI services more than doubled 
(from 42 – 89 patients) in the first year of the study.  Without the results from the ASQ, 37 of these children 
would have missed EI referals and 52.9% of preterm children would not have had early referrals. Rather than 
comparing the questionnaire against a gold standard, refferals from the ASQ were determined as appropriate if 
the child met “real-practice” eligibility criteria used for EI services or qualified for Early Childhood Special 
Education as legislated by the Oregon Department of Education.  Developmental difficulties in 38% of 12 month-
olds and 23% of 24 month-olds were not identified by the paediatricians, whist a ‘wait and see” approach 
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resulted in missed EI referrals of a further  13% of 12-month-olds and 16% of 24-month-olds. Although 
paediatricians’ appraisals were almost always accurate in the children they identified with developmental 
difficulties, they had more difficulty identifying younger infants, lower-risk preterm infants and those with more 
subtle delays. Implementing the ASQ was found to be feasable and possible to administer at low cost without 
impeding office flow. It was strongly recommended for use as a tool for the early detection of developmental 
delay. 
 
10.4.2 PEDS / PEDS:DM 
The PEDS is a very simple tool consisting of only 10 questions which are designed to systematically elicit 
parental concerns. The PEDS has been peer reviewed, validated and standardized. It is an appropriate method 
for use in children from birth to 8 years of age. (102, 103) Its application has recently been expanded by the 
introduction of the PEDS:DM (Developmental Milestones). This is a brief milestone-style checklist from birth to 7 
years 11 months, and can be administered either through the screening/surveillance version, or as an 
assessment-level version for use with programmes serving children at risk (such as NICU follow-up and EI 
services). This version provides both age-equivalent scores, and determines percentage of delay . The 
PEDS:DM has also been standardized, has high levels of validity and reliability and overall excellent sensitivity 
(83%) and specificity (84%). (71) It is recommended that the PEDS and PEDS:DM be used together for optimal 
developmental screening. When used together, the screening test is refererd to as PEDS COMBINED. PEDS 
COMBINED results in more easily triangulating parents concerns and child’s performance, negating the need for 
second stage screening and facilitating rapid referral to EI services when indicated (104). 
 
The PEDS has been used in prevalence studies of developmental disorders (105). It has also been used to 
assess outcomes of parenting and social variables on development (2, 106). It has been validated in the USA 
and trialed in Australia and India (107, 108). It is recommended for use in state-wide child development projects 
like the Assuring Better Child Health and Development (ABCD) project (99).  
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In their 2009 study on practical implementation of the PEDS in an office setting, Schonwald, Horan and 
Huntington (85) reported that practitioners found the PEDS easy to use and because it provided an organized 
structure for discussing parents concerns, it actually saved time during the visit. Several providers noted an 
improved ability to identify developmental concerns following use of the PEDS. The PEDS was given to parents 
in the waiting room whilst they were waiting for their appointment. It was noted that parents consistently had 
enough time to complete the form. They found that it was helpful in reminding them of questions they had 
wanted to ask the doctor and in reminding them about the importance of specific aspects of their child’s 
development. Following implementation of the PEDS in the office setting, significantly more parents reported 
that they had talked with the provider about developmental concerns and significantly more parents reported 
receiving answers to their concerns (ρ = 0.04), despite the providers impressions that they were addressing 
parents’ concern’s at every visit pre-implementation of PEDS. These findings, along with increased identification 
of developmental concerns, have been corroborated by other research. (109, 110, 111) 
 
10.4.3 Comparison of the ASQ and PEDS COMBINED 
Although both the PEDS and ASQ have acceptable psychometric properties and are recommended for 
screening similar population groups, a recently published paper has questioned if these two questionnaires are 
able to concur on which children require additional developmental assessments.  No single pattern of 
discordance emerged, but ratings in the language and communication domain seemed to differ most often 
between the screens (112). It is important to note that the PEDS COMBINED separates language development 
into expressive and receptive language components, whilst the ASQ combines these developmental 
components into one domain. Sensitivity and specificity of the PEDS COMBINED and ASQ are summarized in 
Table 3. 
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Table 3 Sensitivity and Specificity of ASQ and PEDS COMBINED 
 
 
 
 
 
 
 
 
 
In comparing the questionnaires, the PEDS is predominantly designed to elicit parental concerns which are 
validated according to age norms, whilst the ASQ is predominantly a standardised developmental check-list. 
Parental concerns are also elicited, but not statistically validated (86, 88, 103, 113).  
 
Both the ASQ and PEDS:DM are based on developmental milestones. Milestones were chosen according to 
validated, objective measures for the PEDS:DM, whereas ASQ measures were chosen more subjectively and 
then validated. For the ASQ, items that were thought to be easy for parents to observe or ellicit at home were 
selected from from a variety of different sources such as milestone checklists, textbooks and standardized 
developmental tests. The ASQ was then validated as a tool using these items (88). For the PEDS:DM data was 
drawn from standardization and validation studies of the Brigance Inventory of Early Development-II (IED-II) and 
the Brigance Comprehensive Inventory of Basic Skills-Revised (CIBS_R). Binary logistic regression analysis 
was used to determine which items were the most predictive of performance and development difficulties for 
each age in each domain. If more than one item was available, the final item was chosen based on properties 
such as how quickly it could be administered, how easily it could be explained and how likely it was for parents 
to be able to observe the skill. The PEDS:DM was then validated using these items. (71)  
   
The PEDS:DM has a readability two grades lower than the ASQ, making it quicker to read, It contains only one 
item per domain per age level (from 0 – 8 years), whilst the ASQ contains 6 items per domain  per age level 
(from 4 – 60 months). The ASQ consists of several age-appropriate forms and the correct form must be 
 Overall 5-7 months 8 months 10 months 
Sensitivity 70%-90% Not available 51.02% Not 
available ASQ 
Specificity 76%-91% Not available 83.2% Not 
available 
Sensitivity 70%-90% 86% 76% (8 – 10 months) PEDS 
combined Specificity 70%-93% 77% 83% (8 – 10 months) 
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completed at a specific month of age, whereas the PEDS:DM assessment level version is one form that can be 
completed at any age between 0 – 8 years. PEDS is designed to be completed in the office waiting room, whilst 
the ASQ is better suited to be completed in the child’s home setting and then mailed back or brought in for the 
next well-child visit. (71, 88, 113) 
 
In comparing the ASQ and the PEDS; Sices, Stancin, Kirchner and Bauchner (112) concluded that the poor 
concordance between the tools did not negate the importance of screening to prevent under-detection of 
developmental delays, but highlighted the need for further research to compare the performance of these tests 
in the clinical setting. 
 
10.5 Low and Middle Income Countries 
South Africa falls under the classification of Low and Middle Income (LAMI) countries (114). The public health 
care sector reportedly serves 80-85% of the South African population although it accounts for only 39% of the 
total health care expenditure (115, 116). It is therefore important to orientate developmental screening and EI in 
South Africa within the context of LAMI countries. 
 
The causes of developmental disability in children from developing countries are often similar to those from 
developed countries, however additional risk factors amplify adverse outcomes. These may include poverty and 
poor resources; HIV; infections like TB meningitis and cerebral malaria; and nutritional deficits. In LAMI 
countries very small premature babies are less likely to survive due to lack of sophisticated NICU care but LBW 
infants and birth complications are common. These infants survive and may have developmental outcomes 
similar to those of the more premature and ELBW infants who survive in developed countries. Information about 
long-term outcomes following neonatal high-risk conditions in LAMI countries is inadequate. (117, 118) 
 
A 2007 review addressing childhood development and disability in low and middle-income (LAMI) countries 
(117) found large gaps in the knowledge of screening, service provision, policies and legislation. Only four 
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studies from South Africa were included, despite the wide eligibility criteria for papers (with no limitation on year, 
type of study or quality). In their review on LAMI countries the Ten Questionnaire (TQ) was the most commonly 
used screening tool. This tool was developed for use in identifying severe childhood disability and has been 
shown to be ineffective in identifying less severe forms of developmental disabilities such as moderate mental 
retardation. Most studies were cross-sectional and could not track changes over time. A need for longitudinal 
studies to assess outcomes from different types of service utilization was therefore highlighted. Longitudinal 
studies are also necessary for better estimates of the burden of childhood disability and the gaps that exist in 
health-related services in LAMI countries. No studies in the review addressed the issue of cost of early 
intervention and there was a lack of knowledge about the effectiveness of early intervention programmes. The 
review also found little information in the literature about health-related policies and legislation regarding 
childhood disability in LAMI countries, including South Africa. In the presence of limited budgets, research into 
the cost-effectiveness of interventions is essential with policies and legislation being critical in enabling effective 
utilization of available resources. 
 
 “Successful school entry and primary school completion are substantive challenges facing many children in 
developing countries. Without identification and support, children with neurodevelopmental disabilities may not 
even begin to achieve these two central benchmarks of successful development” (118)  
 
10.5.1 Recommendations 
There is a great need for culturally appropriate interventions that can be sustained in LAMI countries. 
Intervention is crucial for these children to improve their health related QoL and break the cycle of poverty. 
Failure to recognize the impact of developmental disabilities along with the lack of developmental experts and 
financial resources has resulted in very few EI programmes. There is therefore a need for research to identify 
and define the necessity for intervention in these countries by following the natural history and impact of various 
conditions, particularly the combined effect of negative insults experienced by children in LAMI countries. 
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Longitudinal monitoring of outcomes of interventions is also crucial to ensure their appropriateness and 
effectiveness. (40, 117, 118) 
 
Recommendations for LAMI countries are to use tools that are easy to administer and that screen for disabilities 
in children less than 3 years of age. Tools must also provide knowledge and supportive services to families and 
their children. Using tools that have been standardised in other countries do not take cultural differences into 
account and decreased levels of validity and reliability may occur once the tests have been translated into the 
native language. A dilemma exists however, as the cost and time needed to develop culturally specific tools and 
perform extensive psychometric testing on them, particularly in light of the limited expertise and funding 
available in LAMI countries, is a barrier to validation studies. (114) 
 
It has been suggested that children from different populations may attain developmental milestones at similar 
ages, possibly eliminating the need to standardize and validate instruments on developmental milestones in 
each country (119). Ethnic differences in the attainment of milestones does occur and socioeconomic factors 
have a marked influence (14). Validation studies on the ASQ in the USA, Canada, Korea, Holland and Norway 
have been done on a wide variety of infants. Although these are first world countries, populations representing 
all socioeconomic levels and many different ethnic groups were used in the validation studies (100). The ASQ 
was also chosen to follow-up children in a large, international multicentre trial (89), run in 33 countries (including 
South Africa) specifically because of low cost and flexibility across a wide range of cultures. In this study 
(involving 828 children, two-thirds of which were from developing countries), ASQ specificity was 82.3% and 
sensitivity was 87.4% showing acceptable psychometric properties in LAMI countries and supporting the ASQ 
for use in low-cost, large-scale screening and monitoring of childhood development. 
 
Ertem et.al. (119) emphasized the need for using standardised tools in LAMI countries where studies have 
shown health care providers are not well equipped with knowledge about early childhood development. Family 
centered methods for monitoring child development, such as parent-administered questionnaires, are highly 
recommended in light of the fact that caregivers in LAMI countries are a key resource to support their child’s 
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development. When selecting which screening tools to use, the authors caution against those developed for 
high-income countries due to lower literacy levels and cultural differences found in LAMI countries. Both the 
ASQ and PEDS have been validated and used in low socio-economic groups where literacy levels and cultural 
influences may be similar to LAMI countries, supporting their use in this context. (88, 102).  
 
10.5.2 The South African Context 
Private health care services in South Africa offer more first world medical care than is possible in the public 
sector. A recent study looking at NICU care in both public and private hospitals in South Africa found the private 
NICUs met many of the international standards. They had enough staff to exceed the nurse:baby ratios of 1:2; 
nursing staff were knowledgeable and worked under the supervision of neonatologists and all babies requiring 
ventilation were ventilated regardless of birth weight. All babies on oxygen were also appropriately monitored 
and screened on a regular basis for retinopathy of prematurity (ROP). In contrast public NICUs often had a 
shortage of monitoring equipment and staff. The nurse:baby ratio regularly reached 1:4 and units were 
understaffed or staffed by nurses with insufficient training. In some public NICUs there were no resident medical 
officers at night and only general duty doctors on call. Monitoring for ROP was frequently non-existent.  There 
was a general policy of not ventilating ELBW babies and knowledge of standard NICU care by lower level staff 
(such as oxygen saturation levels) was insufficient (116).  
 
Despite these differences in standards of care, Cooper and Sandler (120) reported comparable outcomes and 
rates of handicap at 18 months in a cohort of VLBW infants from a public sector hospital in Soweto, South Africa 
to those from developed countries. Similar to international studies, South African studies from 1985-1999 have 
shown improved survival of NICU infants but with a resultant high prevalence of developmental delay. Lower 
SES, particularly maternal education, was found to be a predictor of lower developmental scores for NICU 
infants in South Africa (120,121, 122, 123, 124,125).  
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The private health care sector serves only 15-20% of the population but is responsible for 61% of the total 
health expenditure (115). In 1981, a survey of all paediatricians registered with the South African Medical and 
Dental Council showed 45% of registered paediatricians worked in private practice (126), however no 
publications on the practice of general developmental screening by paediatricians in private practice in South 
Africa could be found. Studies on newborn hearing screening and screening for ROP in public and private 
hospital settings are available, as well publications on screening and EI related to speech, language and 
audiology. (115, 116, 127, 128, 129) 
 
10.5.2.1 Early Intervention 
In line with international research on EI described in this review, outcomes of children who received Cochlear 
implants in the Pretoria Cochlear Implant Programme indicate that key factors related to positive outcomes in 
South African children’s audiological, linguistic, social and educational functioning were early age at diagnosis 
and early intervention (130).  
 
HI-HOPES is an EI programme launched in 2006 at the Wits Centre for Deaf Studies in Gauteng, South Africa, 
servicing all economic sectors (131). Private practitioners referred 19% of infants on the programme, compared 
to 22% being referred via word of mouth and media advertising. The remaining infants were referred by public 
and private hospitals (56% and 3% respectively). Analysis of this programme shows the average age of initial 
registration with the programme was 25 months, with the majority of infants having profound or severe to 
profound hearing loss. The average age of initial diagnosis was 15 months, indicating a significant gap of nearly 
a year between diagnosis and intervention. This is despite the reported intervention guidelines for children with 
hearing loss recommended by the Health Professionals Council of South Africa. These guidelines state that the 
identification of potential hearing loss should occur by 1 month of age, diagnosis confirmation by 3 months of 
age and referral to EI before 6 months of age (131).  
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The value of these guidelines are shown in the test results of infants on the HI-HOPE programme. There was a 
marked difference in improvement of both receptive and expressive language in children identified before 7 
months of age compared to those identified later. These findings of late identification and implementation of EI 
were similar to another South African Study looking at the identification and treatment of children with early 
onset hearing loss in Pretoria, where the mean age of diagnosis was 23 months and the mean age of initial 
hearing-aid fitting was 28 months, with referral to an EI programme only at a mean age of 31 months (132). 
 
10.5.2.2 Developmental Screening 
In assessing developmental screening practices in South Africa, only research on screening for the early 
detection of hearing loss and retinopathy of prematurity (ROP) was found (116, 133). These research reports 
noted that the vast majority of public sector hospitals in South Africa do not provide screening services. More 
than 80% of eligible premature babies were not examined for ROP and more than 90% of babies were not 
assessed for early detection of hearing loss.  
 
Varughese, Gilbert, Pieper and Cook (116) estimated at least 260-300 babies were at risk for ROP each year in 
South Africa, with at least half of whom would become blind without treatment. Paediatricians in their study 
reported that they were not seeing blind babies coming back for follow-up after NICU discharge, but a study of 
children in blind schools in South Africa showed that ROP accounted for 10.6% of blindess. This clearly shows 
how ineffective screening practices result in lack of intervention and poor outcomes.  Similarly, Swanepoel, 
Ebrahim, Joseph and Friedland (115) reported less than 7% of babies requiring hearing aids received them 
before 6 months of age, loosing critical time for improving language outcomes in the population. Both of these 
studies were published recently (2007 and 2008) showing a serious lack in implementation of screening 
programmes despite the government’s commitment to the early identification of disabilities in 1997 (134).  
 
Lack of equipment and staff shortages were the most frequently reported reasons for not having screening 
programmes. A lack of funding cannot be entirely to blame however as a similar lack of screening programmes 
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for hearing difficulties was noted in the South African private sector hospitals (115). Inconsistencies in the 
services provided, the type of screening used and the population groups targeted may well be due in part to lack 
of legislation or formal policies from the Department of Health and Government. Screening programmes have 
become part of standard childcare in other countries through definitive actions from policymakers. For example 
in North Carolina the states Medicaid programme has the right to refuse payment for a well-child visit unless the 
visit includes a developmental screen (62).  
 
10.5.2.3 Resources 
The dire situation of under-detection and under-treatment of children in South Africa was highlighted in a 2007 
study looking at services for children in need of rehabilitation in a peri-urban township of South Africa. Only a 
quarter of children in need of rehabilitation actually received it and nearly half of all children with motor or 
intellectual impairments were not attending school (135).  
 
In South Africa where resources are limited, rehabilitation can seem less of a priority than other essential health 
services. Properly allocating available resources may result in improved ability to provide rehabilitation services 
to South African children however, without increasing the financial burden on the country. A simple example of 
this is that the cost to society of looking after one blind child for life could have covered the costs of a significant 
amount of preventative screening and intervention programmes. (116) 
 
The long-term implications of missed opportunities for EI need to be considered. The cost of childhood disability 
extend past the child and immediate family to affect the community and society as a whole. Children who do not 
reach their full potential are less likely to be productive adults. Poor levels of cognition and education are linked 
to lower earnings, negatively impacting the next generation. Improved education is linked to lower teenage 
pregnancy rates and improved outcomes for infants, which include improved health, nutrition, cognition and 
education. The total cost to society of poor early childhood development therefore needs to include the costs 
born by subsequent generations, before being weighed up against the immediate cost of early intervention (40).  
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10.5.2.4 Recommendations 
Because the effect of interventions on the infant and child may only be realised in adulthood, long-term 
neurodevelopmental monitoring of children is essential to assess outcomes of interventions and inform policy. 
Without long-term monitoring of children, needs cannot be accurately identified and ‘best practice’ clinical 
guidelines cannot be determined (119, 136).  
 
There is considerable empirical evidence that parent-administered questionnaires are an effective 
developmental monitoring tool (4, 57, 137). They have been shown to be as accurate as physician- 
administered screening tools in identifying delayed or disordered development. They are brief to administer and 
relatively inexpensive, making them practical to implement at regular intervals.   
 
Early detection using standardised parent-administered screening tools has become an important health care 
strategy in high-income countries (119). In the South African context parent-administered questionnaires could 
be a practical and affordable solution to implementing more structured screening and monitoring, comparable 
with international standards. 
 
“Unfortunately, death is the tip of the iceberg… failure of children to fulfill their developmental 
potential and achieve satisfactory educational levels plays an important part in the 
intergenerational transmission of poverty … In view of the high cost of poor child development, 
both economically and in terms of equity and individual well-being, and the availability of 
effective interventions, we can no longer justify inactivity.” (40)  
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10.6 Summary 
The importance of early identification to facilitate early intervention, research and policy is highlighted, with the 
use of parent-administered questionnaires being well justified due to minimal costs and a strong family-centered 
approach, affording long term benefits to the child, family and society. 
 
The PEDS COMBINED and ASQ are good quality parent questionnaires that have acceptable psychometric 
properties and are frequently referenced and recommended for use in the literature on developmental 
screening. Using these screening tools in a population of infants who have required neonatal intensive care can 
be expected to produce a substantially greater number of positive screens (30% - 70%) than using them in the 
general population (10%). Information on how well the two tests concur and on their use in the South African 
context is inadequate and further research into these areas is needed. 
 
Information on developmental screening practices in South Africa by paediatricians in the private sector over the 
past 10 years is sparse. Considering the large body of scientific literature available on this topic internationally, 
investigation into the screening practices of South African paediatricians is warranted. 
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11 Aims & Objectives 
The objective of this study is to look at the concordance between the ASQ, PEDS COMBINED and the PSA in 
the early detection of developmental delay in a group of high-risk infants in the private health care sector of 
Gauteng, South Africa.  
 
This study does not attempt to determine which method is more psychometrically sound or accurate in detecting 
developmental delay and is not an attempt to standardize these screens for the South African population. The 
aim of this study is to add to the growing body of literature on parent-administered questionnaires and to identify 
some of the trends of pediatricians in Gauteng, South Africa in screening for developmental delay 
“It is unlikely that randomized, controlled trials will clarify a single best tool or method for efficient and 
effective screening for all practitioners. Rather, the cumulative experiences shared across regions, 
practice settings, and with varying tools inform providers of the feasibility and effectiveness of the 
range of methods available for transforming developmental screening into an evidence-based 
practice.” (111)  
 
12 Rationale and Research Questions 
The ASQ and PEDS are two parent-administered questionnaires that are commonly recommended for use in 
the detection of developmental delay with favourably reported psychometric properties.  They should therefore 
have a high convergent validity and concur on which infants or children in an assessed group are at risk for 
developmental delays. In September 2009, the first study to look at the concordance between the ASQ and 
PEDS was published (112). The data for the study were part of a larger study, not originally intended to 
compare the two questionnaires. The study found only moderate agreement and significant discordance 
between the ASQ and PEDS and called for further research to better understand the uses, limitations and 
performance of these two questionnaires. 
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The ASQ and PEDS COMBINED (using the PEDS:DM Assessment Level Version) are recommended for 
screening high-risk population groups, including infants in NICU follow-up programmes. Infants with perinatal 
complications requiring admission to a neonatal unit are at higher risk for developmental delay with 44% - 76% 
requiring special education by school-age compared with 10% of the general population (26, 66). A population 
of high-risk infants who had required NICU care was therefore chosen to increase the likelihood of positive 
screens in this study. 
 
There have also been no papers published on the methods and ability of paediatricians in private practice in 
South Africa to detect developmental delay.  The knowledge and use of standardised parent-administered 
screening tools used by these paediatricians is not known.  
 
The current study is therefore a comparison of 3 different methods of screening for developmental delay in at-
risk infants in the private health care sector of the southern Gauteng region of South Africa. It compares 
recommendations from the ASQ, PEDS COMBINED and paediatricians’ subjective assessment (PSA) practices 
for a cohort of at-risk infants from neonatal intensive care units in this region. This study will also identify trends 
in developmental screening practices and in the knowledge and use of parent-administered screening tools in a 
diverse group of paediatricans working in the southern Gauteng region of South Africa.  
 
The following hypotheses will be tested: 
1. The number of infants identified with developmental concerns by the  PEDS COMBINED and ASQ will 
be greater than that identified by the PSA. 
2. The ASQ and PEDS COMBINED will have good agreement, better than that expected by chance 
3. The PSA will have poor agreement with both the ASQ and PEDS COMBINED, less than expected by 
chance 
4. Standardised parent-completed questionnaires are not routinely used by paediatricians in private 
practice in the southern Gauteng region of South Africa at present. 
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13 Methods 
13.1 Population 
This study used an in-subject design with each infant being it’s own control. Subjects were selected through 
non-random criterion sampling using a single cluster design. Clusters included all private hospitals in the 
southern Gauteng region with a full neonatal intensive care unit. Criteria for selection of infants included all 
infants in these clusters who required more than 3 days care in the NICU post-partum and whose caregiver filled 
in a consent form. The criterion for paediatricians included any paediatrician who was identified by the infant’s 
caregiver as the primary paediatrician. (Table 4) 
 
All private hospitals in the Southern Gauteng region that support a neonatal intensive care unit (NICU) were 
contacted for permision to approach caregivers of infants in the hosptial’s NICU. Signed consent was given by 
the hospital managers and either the NICU managers or paediatricians working in the specific units, depending 
on the individual hospital’s policies. Following consent, the hospital was visited between four and six times at 
random from October 2007 until June 2008. At each visit, nursing staff were informed about the study and asked 
to hand out consent forms to caregivers. Posters describing the study with consent forms attached were also left 
in each of the neonatal units. All caregivers present in the unit at the time of the visit were approached, informed 
about the study and given an option to fill in a consent form. (Table 4) 
 
The 6 months corrected age (6mnth CA date) was calculated using the formula recommended in the PEDS:DM 
professional’s Manual   
“subtract 1 month from chronological age if the child was 3 1/2 - 6 weeks premature, 2 months if 
7 – 10 weeks premature, 3 months if 11 to 14 weeks premature, and 4 months if 15 – 18 weeks 
premature“ (104)  
 
Caregivers were contacted to confirm their postal address approximately six weeks before the baby’s 6mnth CA 
date. Questionnaires were posted two weeks later or faxed six weeks later with prepaid envelopes for returning 
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the completed questionnaires, except where the postal address could not be confirmed. Caregivers were 
reminded on two separate occassions by fax, sms or email to return completed questionnaires and were given 
the option to withdraw from the study at any time. 
 
Questionnaires that were returned by the caregiver contained more detailed information about the infant’s 
medical and developmental history. Those infants with reported genetic syndromes were excluded from the 
study, as were those infants who had spent less than 3 days in the NICU.  The infants’ chronological and 
corrected age at the time the questionnaire was completed were calculated by subtracting the birth date from 
the date of testing and then correcting for prematurity as recommended by the author of the PEDS / PEDS:DM 
(104). Returned questionnaires were scored according to the infant’s corrected age and feedback was given to 
the caregivers via an email or faxed letter. 
 
Returned questionnaires included a signed consent for the researcher to contact the infant’s  paediatrican. 
Details of their paediatrician were supplied by the caregiver; including the paediatrican’s name, telephone 
number, date of their last visit and date of their next planned visit. Paediatricans identified in this way were 
informed about the study. They were asked to complete a consent form and fill out a short questionnaire 
regarding their knowledge of parent-administered questionnaires and their developmental screening and referral 
practices. The paediatrician was then asked to complete a form indicating any developmental concerns for their 
specific patient. This was in the form of a checklist that could be filled in and returned by fax or email, or the 
paediatrican could indicate their concerns telephonically. The information obtained in this way was used to 
produce the paedaitrician’s subjective assessment (PSA) for the purposes of this study.  
 
Paediatricians were aware that their patients had filled in a parent-administered questionnaire, but were blinded 
to the recomendations from this questionnaire. To assist with follow-up of their patients they were emailed or 
faxed a short summary of recommendations from the questionnaries once the completed the PSA was recieved.  
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Table 4 Inclusion and exclusion criteria 
  
13.2 Measurements 
(Appendix 18.3 – 18.7) 
 
13.2.1 Ages and Stages Questionnaire (ASQ)  
The ASQ (88) consists of a set of 19 questionnaires divided into the following age groups categorised by 
months 4,6,8,10,12, 14, 16, 18, 20, 22, 24, 27, 30, 33, 36, 42, 48, 54 and 60 months. The questionnaire 
matching the child’s age is given to the care-giver, and requires the caregiver to respond ‘yes’, ‘sometimes’ or 
‘not yet’  to a list of age appropriate activities. Thirty activities are divided into 5 developmental domains: 
Communication domain (Comm); Gross motor domain (GM); Fine Motor domain (FM); Problem solving domain 
(PS); Personal-Social domain (SE) 
Caregiver responses are assigned points: ‘yes’ receiving 10, ‘sometimes’ 5 and ‘not yet’ 0.   The points are 
added up in each of the five domains to give the domain scores, and then added together for a summary score. 
The domain scores and summary scores are compared to a derived screening cut-off score, recommended as 2 
SD below the mean by the user’s manual (88).  
Seven open ended questions to elicit parental concerns are also included in the analysis of the questionnaires, 
but do not form part of the scored evaluation.  
Subjects: Inclusion Criteria Exclusion Criteria 
Infants * Ages between 5 months and 10 months 
* Must have required NICU care within the 
first day post-partum 
* Must have spent more than 3 days in the 
NICU 
* Any infant with a genetic syndrome 
* Infants who spent less than 3 days in the NICU 
* Infants of caregivers who did not give consent 
Paediatrician * Identified by the caregivers of infants on 
the study as their infant’s paediatrician 
* Paediatricians who were not identified by one of 
the included infant’s caregivers as being their 
paediatrician.  
* Paediatricians who did not give consent 
Hospitals *All private hospitals in Southern Gauteng 
with a fully functioning NICU 
* Hospitals where the hospital management did 
not give consent 
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13.2.1.1 Rating the ASQ scores  
(Table 5) 
For the ASQ, a referral cut-off point of 2 SD below the mean for each domain is used to identify those babies 
who need further assessment.  Children scoring above this are classified as age appropriate. The user’s guide 
also recommends following-up infants whose caregivers have indicated in the open questions that the infant 
does not use two hands equally or does not stand on flat feet since these questions were specifically added to 
assist in detecting cerebral palsy (88).  
For the purposes of this study the following scoring system was used (Table 5): 
1- Any baby scoring at or more than 2 SD below the mean in a domain was given a rating of 1 for that 
domain. A rating of 1 was also given for the FM domain if a caregiver answered “no” to the questions 
about their infant’s equal hand use and for the GM domain if the caregiver indicated the infant was toe-
standing. 
2- An arbitrary cut-off score of 1 SD below the mean was used to identify those babies that needed to be 
monitored more closely than normal. Any domain that was scored between 1 and 2 SD below the norm 
was given a rating of 2.  
3- Any child scoring within the normal range and up to 1 SD below the norm was given a rating of 3.  
 
13.2.2 PEDS COMBINED  
The PEDS COMBINED consists of two questionnaires which can be used together, the PEDS and PEDS:DM. 
The PEDS is a very simple tool, consisting of only ten questions which are designed to systematically elicit 
patental concerns in the domains of GM, FM, PS, SE, Comm (seperated into expressive and receptive 
language), as well as global and pre-school skills. Caregivers circle one of three provided options, namely ‘yes’, 
‘no’ or ‘a little’. These responses are then transferred to a scoring sheet which indicates which concerns are 
significant and predictive of developmental concerns according to the child’s age, and recommends a course of 
action.  
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The PEDS:DM is a milestone checklist. It is designed to be used either as a screening tool or as an assessment 
level tool. The assessment level version uses the same items as the screening tool. It groups items by domains 
instead of ages and presents them as a continuous set of tasks so that items above and below the child’s age 
can be scored. This results in the test being able to show a child’s strengths and weaknesses. This also allows 
the user to determine age equivalents and percentage delay rather than just providing a cut-off score based on 
standard deviations below the mean. According to the author of the PEDS:DM  the continuous item set allows 
for identification of emerging skills as well as mastered skills, which facilitates progress monitoring and is useful 
for programme evaluations and research studies. The PEDS:DM covers the same developmental domains as 
the PEDS. 
 
The assessment level version was used for this study. It can be used continuously for infants up to 8 years and 
therefore contains many items not applicable to the age of the study population group. The author was 
contacted and gave permission via e-mail to restrict the item sets for this study.  
 
13.2.2.1 Rating the PEDS COMBINED scores 
(Table 5) 
The PEDS COMBINED is designed to lead a practitioner down several paths requiring different actions 
depending on the scored results (104). These were summarized into one of three recommendations as shown in 
Table 5, with a resultant rating of:  
1. Refer for in-depth assessment,  
2. Monitor closely or  
3. Age appropriate 
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13.2.3 Paediatricians 
Paediatricians in this study were asked to rate the infants development based on their normal practice 
procedures and then to mark a checklist rating their opinion of the infant’s development. The result was the PSA 
 
13.2.3.1 Rating the PSA Scores  
(Table 5) 
The paediatricans were asked to rate the infant’s development as,  
1- Delayed - refer for in-depth assessment / intervention,  
2- Concerned - monitor closely or  
3- Not concerned at this time.  
These were given the same rating of 1, 2 or 3 respectively for the purpose of this study (Table 5). 
4- Infants could also receive a rating of 4 if the paediatrician had not seen the infant in more than four 
months and was therefore unable to comment on the infant’s current development. This was 
determined if 
a. caregivers indicated on their forms that they had not seen their paediatrician for more than 
four months and had no follow-up visit planned, or  
b. the paediatrician reported that they had not seen the infant for more than four months.  
 
13.2.4 Summary scores  
The infant was determined to have failed (ie. They had a positive screen indicating a referral for further 
assessment was needed) if they failed any domain. This was recommended in the user manuals (88) and was 
also used by Sices, Stancin and Kirchner in their study comparing the ASQ and PEDS (112).  In other words, 
they received a summary score of 1 if a rating of 1 was received in any of the domain scores. A summary score 
for each of the parent-completed questionnaires and for the PSA was therefore derived and determined by the 
lowest value of their respective domain scores (Table 5). A summary score was given as follows:  
1- If the screen scored a 1 in any domain, it was given a summary rating of 1.  
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2- If the screen did not have 1's, but had a 2 in any domain, the summary rating was 2.  
3- If the screen did not have 1s or 2s, the summary rating was 3 
4- If the infant had not seen the paediatrician in more than 4 months and had no planned visits, 
the summary rating was 4 
 
Table 5  Rating of Three Methods 
 
 
13.3 Statistical Methods 
Data was collected in clusters from each hospital and then analyzed at the individual infant level. To determine 
sufficient sample size we made the assumption (based on the literature) that in our high-risk group at 6 months 
corrected age 70% of infants should pass the screen (receive a rating of 3) (21). A sample size of at least 38 
subjects would be required to have power in excess of 80% to detect excellent agreement (κ ≥ 0.8) compared 
to the upper limit of poor agreement (κ = 0.4) when testing one sided at the 0.05 level of significance. When 
comparing the PEDS and ASQ, we had a sample size of 60 when comparing rating 1, 2 and 3; and a sample 
size of 43 when comparing rating 1 and 3 only. Our sample size was therefore sufficient to analyze the 
agreement between the PEDS and ASQ using the intraclass kappa coefficient. (Table 6) 
 
In assuming a pass rate of 70%, a sample size of at least 23 subjects will have power in excess of 90% to 
detect poor agreement (κ < 0.4) compared to excellent agreement ((κ≥ 0.8) when testing one sided at the 0.05 
level of significance. When comparing the PSA rating and ASQ or PEDS COMBINED, we had a sample size of 
32 and 35 respectively when for rating 1, 2 and 3; and a sample size of 24 and 27 for rating 1 and 3. Our sample 
Rating ASQ PEDS COMBINED PSA 
1 
2 or more SD below mean 
OR toe-standing  
OR child not using hands 
equally well 
Path A PEDS 
OR 
Fails 1 or more items on PEDS:DM 
Delayed - refer for in-depth 
assessment / intervention, 
2 
Between 1 & 2 SD below 
mean 
Path B, C or D on PEDS 
AND 
Passes all items on PEDS:DM 
Concerned - monitor 
closely 
3  
Up to 1 SD below mean   Path E on PEDS  
AND 
Passes all items on PEDS:DM 
Not concerned at this time  
4 - - Unable to follow-up 
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size was therefore sufficient to analyze the agreement between the paediatricians and each of the 
questionnaires using the intraclass kappa coefficient. (Table 6) 
 
Table 6  Sample size calculations 
 
The data were analysed to compare if the screening methods identified the same infants as developmentally 
appropriate (rating 3), being at-risk for developmental delay (rating 2) or developmentally delayed (rating 1). 
Comparisons were made between:  
1 - ASQ & PEDS COMBINED 
2 - ASQ and PSA 
3 - PSA and PEDS 
The kappa coefficient (κ) was used to assess if the agreement between the two screening methods in each pair 
was greater than that expected by chance, with a coefficient of ≤ 0.4 indicating poor agreement, 0.4 to 0.75 
moderate agreement and ≥ 0.75 excellent agreement (138). To analyze how the number of children who 
passed each screen compared, a test of symmetry was used. The test decision was determined by a chi-
squared calculation with a ρ-value < 0.05 indicating statistical significance. (Appendix 18.8.1) 
 
The data were then analysed excluding the rating 2 as the ASQ is designed to screen positive or negative 
(rating 1 or rating 3). A rating of 2 was derived for this study in an attempt to compare the ASQ in a more similar 
manner with the PEDS COMBINED, but which had not been validated for the ASQ. A rating of 2 was given to an 
infant who was not age appropriate, but also not significantly delayed, with recommendations for closer 
monitoring, but not for a more in-depth assessment. To compare the ability of the thress screening methods to 
differentiate between those infants who should be referred for an in-depth developmental assessment and those 
 80% power to detect excellent 
agreement between questionnaires 
((κ ≥ 0.8) 
90% power to detect poor agreement between 
paediatrician and questionnaires 
(κ < 0.4) 
 ASQ:PEDS 
1,2,3 
ASQ:PEDS  
1 & 3 
ASQ:PSA 
1,2,3 
ASQ:PSA 1 
& 3 
PSA:PEDS 
1,2,3 
PSA:PEDS 1 
& 3 
Sample size 
required 
38 38 23 23 23 23 
Actual sample 60 43 32 24 35 27 
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developing appropriately, the rating of 2 was removed from the analysis, as it did not fall into either category. 
Sices et al. (112) compared the ASQ and the PEDS in the same way. 
 
If an infant had not been seen by their paediatrician for more than 4 months, a rating of 4 was given to the PSA. 
Data where infants scored a 4 on the PSA were not used in calcultions and analysis of kappa or symmetry when 
comparing the PSA to the questionnaires but were used in the descriptive analysis of results.  
 
13.4 Ethical Considerations 
The study was approved by the Human Research Ethics Committee (Medical)- Protocol M070416 (Appendix 
18.1). Consent forms were obtained from participating hospital managers and NICU managers as well as all 
parents and of infants participating in the study. Consent forms were also obtained from paediatricians 
participating in the study. All participants were given the option to withdraw from the study at any time without 
consequence. (Appendix 18.2) 
 
Parents were provided with contact details of the researcher in order to answer any questions or address any 
anxiety that may have occurred as a result of participating in this study. Parents received feedback in the form of 
a letter and were directed to their paediatrician to assist with any follow-up of recommendations from the 
screening. Paediatricians were provided with a summary of screening results to facilitate follow-up of any 
concerns raised by the questionnaires.  
 
Hosptials, paediatricians’ and infant-caregiver pair details were coded to ensure confidentiality. Caregivers were 
asked to use a specific code on the questionnaires and not to put their infant’s names or other identifying 
information. Names and contact details were kept in a separate file, locked with an alphanumeric pin code.  
 
No funding or financial support was received for this study. 
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14 Results 
 
14.1 Descriptive Analysis 
14.1.1 Questionnaires 
A total of 17 hospitals were identified as appropriate for this study and contacted for permisson to recruit 
subjects in their NICU’s. Management from 15 hospitals gave consent and each of these hospitals was visited at 
random between 4 and 6 times by the researcher. At the end of the collection period, an average of 4 consent 
forms were obtained from each hospital (minimum: 0, maximum:16, SD: 5). This resulted in consent forms being 
obtained for 133 infants. Of these, 68 caregivers did not return questionnaires. Fifteeen caregivers could not be 
contacted and therefore were not sent questionnaires, 2 infants’ caregivers declined to participate in the study, 2 
infants had died and 1 infant was excluded from the study because of Down Syndrome. This resulted in 113 
questionnaires being posted, of which caregivers returned 65 (57.5 %). (Figure 1) 
 
Figure 1 Consent Forms Received 
 
 
Of the 65 questionnaires that were returned, a total 60 ASQ forms were received (92%) and 65 PEDS 
COMBINED forms were received (100%). A total of 38 paediatricians were identified on the returned 
questionnaires and were contacted by the researcher. Of these 38 paediatricians 24 consented to particpate in 
the study, completing a total of 35 PSAs (54% of the 65 questionnaires returned).  An average of two PSAs 
were completed per paediatrician (minimum: 1, maximum: 6, SD: 2). (Figure 2) 
85% 
11% 1% 
2%  1%  Consent Forms(n=133) 
Questionnaires Posted (113) Unable to contact (15) Declined to particpate (2) Died (2) Excluded (1) 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Figure 2 Summary of Study Design 
 
 
There were 30 infants for whom no paediatrician’s opinion was available. Of these 30 infants,16 (25%) did not 
receive a paediatrician’s opinion because the paediatrician did not participate in the study, whilst the other 14 
(21%) infants had not seen their paediatrician within the required time frame and thererfore received a PSA 
rating of 4. These infant’s caregivers most often reported that they had not been back to the paediatrician due to 
financial restraints or because they did not see the necessity of a well-baby follow-up. Of these 14 infants who 
were not seen by a paediatrician for follow-up, ten were identified by the parent-administered questionnaires as 
having significant developmental delays. Infants who received a rating of 4 showed the same demographic 
variables as the rest of the studies cohort - they were mostly white, lower risk NICU infants and did not cluster 
around a particular hospital or paediatrician.  
 
14.1.2 Patient Characteristics 
Population variables of the cohort are presented in Table 7. Infants were mostly white, lower-risk premature 
infants.The average age of the infants when the ASQ and PEDS COMBINED was completed was the same as 
the average age of the infants when the PSA was completed (6 months, SD:1 and 6 months, SD:2 respectively).  
 
Get consent from hospitals to collect consent forms in their NICU 
17 Hospitals Identi`ied  15 Hospitals gave consent 
Visit Hospitals to collect consent froms 
133 consent forms collected  
Send out Parent Packs 
113 Parent Packs sent out  65 Parent Packs returned 
Score Returned Questionnaires from Parents 
60 ASQ's returned 
ASQ Rating  
65 PEDS Combined returned 
PEDS Combined Rating 
Conact Paediatricians identi`ied by participating parents 
38 Paeds Packs sent out  20 Paeds gave consent  Paeds reported on 35 Infants 
PSA Rating 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Table 7  Patient Characteristics 
Patient Characteristics 
Total Number (n)  65 % 
Birth weight (g) mean ± SD 
1796 ± 
825  
 range 490 - 4270  
Gestational age (weeks) mean ± SD 34 ± 3.4  
 range 26 - 42  
Sex (n) male 27 42% 
 female 32 49% 
 unknown 6 9% 
Race (n) White 51 79% 
 Black 10 15% 
 Indian 4 6% 
Reason for NICU Admissions (n) Low birth weight / Prematurity 51 79% 
 Respiratory Complications 11 17% 
 Neonatal Infections 2 3% 
 Congenital Abnormalities 1 2% 
Number ventilated (n)  36 55% 
Length of NICU Stay (days) mean ± SD 27 ± 31  
 range 4 -131  
Age when questionnaire completed (months) mean ± SD 6 ± 1  
 range 6 -10  
Age at paediatrician visit (months) mean ± SD 6 ± 2  
 range 5 - 9  
 
 
14.1.3 Identification of Developmental Concerns 
Of the total group of 65 infants whose caregiver’s completed questionnaires, 6% (4) were identified with 
developmental concerns by the PSA. The ASQ identified 37% (24) and the PEDS COMBINED identified 42% 
(27) of the infants as having developmental concerns requiring further developmental assessment. (Figure 3) 
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Figure 3 Identification of infants requiring in-depth developmental assessment 
 
 
In total 44 of the 65 infant’s (68%) had all three screening methods returned. In this group all infants had an 
ASQ and PEDS COMBINED and infants either had a PSA from the paediatrician or it was reported that they had 
not seen the paediatrician for more than 4 months. Of the 44 infants in this group, up to 38% were identified with 
58% 
42% 
PEDS COMBINED (n=65) 
age appropriate (38) 
Delayed (27) 
60% 
40% 
ASQ (n=60) 
age appropriate (36) Delayed (24) 
92% 
8% 
PSA (n=49) 
age appropriate / unable to follow‐up (45) Delayed (4) 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developmental concerns by the questionnaires, whereas only 6.8% were identified with developmental concerns 
by the paediatricians. (Figure 4) 
 
Figure 4 Comparison of recommendations by three screening methods 
 
 
In the total group of 65 infants for whom questionnaires were received, gross motor concerns were the most 
frequently identified concerns by all 3 screening methods. The PEDS COMBINED also identified a higher 
number of children with communication concerns than the other screening methods. The paediatricians 
identified the least number of concerns in all domains . (Figure 5) 
0 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35 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No. of infants recommended for further assessment (rating1) 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infants not recommended 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further assessment (rating 3 or 4) 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 17 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PEDS COMBINED ASQ 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Figure 5 Number of concerns per developmental domain (rating 1)  
(GM=Gross Motor, FM=Fine Motor, Comm = Communication, SH=Self Help, SE = Social Emotional) 
 
 
14.1.4 Referral Practices of Paediatricians 
Paediatricans were selected for this study if they were identified by the caregiver as the infant’s primary 
paediatrician. These paediatricians were asked to complete a short questionnaire describing their screening and 
referral practices and a total of 23 questionnaires were returned. Of these, the percentage of paediatricians who 
indicated that they would commonly refer babies under 12 months old with a non-specific, mild developmental 
delay for physiotherapy was 82.6%, for speech was 47.8% and occupational therapy was 39%. 
 
Only three paediatricians indicated that they based their referrals on specific guidelines whereas all of the 
paediatricians indicated that they based their referrals on clinical judgment and experience. More than half of the 
paediatricians, (52%) felt that caregivers were unable to identify developmental delay in their own babies whilst 
13% felt that some caregivers were able to and some were not. Less than 35% indicated that they thoughT 
caregivers were able to identify developmental delay in their own babies.  
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Knowledge about parent-administered questionnaires for developmental screening was limited amongst the 
paediatricians, with only five paediatricians (21%) indicating any knowledge about parent-administered 
questionnaires, and none of the paediatricians surveyed able to actually name the ASQ or PEDS. No 
paediatrician surveyed had experience using parent-administered questionnaires in their practice.  
 
Of the 65 infants on the study, seven had been for therapy (11%). Of these, two went for both physiotherapy 
and speech therapy, two had only physiotherapy, two had only speech therapy and one had occupational 
therapy. Information on who had initiated the referral was not available. (Figure 6) 
 
Figure 6 Therapy Referrals 
 
 
14.2 Comparitive Analysis    
14.2.1 Comparison of rating 1 & 2 
The ASQ and PEDS COMBINED showed excellent interrater agreement, agreeing on which infants required 
further developmental assessment (Figure 7). When there was discordance it was not random. Discordance 
occurred in the direction of the ASQ being more likely to identify an infant as delayed, except in the domain of 
communication where the PEDS COMBINED was more sensitive than the ASQ. The PSA was more likely to 
identify infants as age appropriate across all domains and for overall development, and therefore the least likely 
0 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20 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40 50 
60 70 
No Therapy  OT  Physio  Speech 
Therapy Referrals 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to recommend further developmental assessment or intervention for an infant (Table 8). The PSA showed poor 
agreement with both of the standardised parent-administered screening tools overall in identifying infants as 
delayed (Figure 7). These results are described in more detail below. 
 
Figure 7 Kappa comparisons of Rating 1 & 3 
(GM=Gross Motor, FM=Fine Motor, Comm = Communication, SH=Self Help, SE = Social Emotional) 
 
 
14.2.1.1 Summary Scores  
(Table 8) 
The concordance between the ASQ and PEDS COMBINED expected by chance was 49.8%. The actual 
concordance between the two questionnaires was 90.7% (κ = 0.82, p = 0.05). The excellent agreement 
between the two questionnaires was therefore statistically significant and significantly greater than that expected 
by chance. When there was disagreement between the two questionnaires, the discordance of 9.3% was in the 
direction of the ASQ rating an infant as 1 when the PEDS COMBINED rated the same infant as 3 (ρ = 0.05) 
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The concordance between the PEDS COMBINED and PSA was poor and statistically significant (κ = 0.28, ρ = 
0.03). Discordance was significantly in favour of the PEDS COMBINED identifying the infant as delayed when 
the PSA identified the infant as age-appropriate. 
 
The concordance between the ASQ and the PSA was poor and statistically significant (κ = 0.26, ρ = 0.01). 
Discordance was significantly in favour of the paediatrican identifying the infant as age appropriate whilst the 
ASQ identified the same infant as needing further assessment. 
 
14.2.1.2 Domain Scores  
(Table 8) 
For the GM domain, there was moderate agreement between the ASQ and PEDS COMBINED (κ = 0.66) and 
poor agreement between the PSA and both questionnaires (κ < 0.4). Discordance in this domain was not 
significant.  
 
For the communication domain, poor agreement between the ASQ and PEDS COMBINED was significant (ρ = 
0.01, κ = 0.19), with the ASQ being more likely to identify an infant as age appropriate whilst the PEDS 
COMBINED identified the same infant as requiring further assessment. Poor agreement between the PEDS 
COMBINED and the PSA was also significant for communication (ρ = 0.01 & κ = 0.20). Discordance was 
directional with the PEDS COMBINED more likely to recommend further assessment when the PSA identified 
the infant as age appropriate. The ASQ and PSA showed poor agreement, which was not statistically significant 
or directional. 
 
For SH, SE and FM domains there was moderate agreement between the PSA and PEDS COMBINED which 
was not significant (ρ > 0.05) with random discordance. In other words the agreement was not different from 
that expected by chance. When the PSA and PEDS COMBINED disagreed, the disagreement was not in any 
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direction. There was also poor agreement and random discordance in these domains when comparing the ASQ 
to the PEDS COMBINED and PSA. The negative kappa score in the SE domain was not significant. 
 
Table 8  Comparison of rating 1 & 3 
(GM=Gross Motor, FM=Fine Motor, Comm = Communication, SH=Self Help, SE = Social Emotional) 
Rating 1,3 Kappa Symmetry : Summary Symmetry: Domain 
ASQ: PEDS 
COMBINED 
Excellent agreement 
for summary  
(κ= 0.82) 
Moderate agreement 
for GM domain 
(κ= 0.53) 
Borderline significant 
discordance is 
directional with a trend 
towards PEDS 
COMBINED being 
more likely to score a 3  
(ρ = 0.05) 
Statistically significant 
discordance is directional for 
Comm with ASQ more likely 
to score a 3  
(ρ = 0.01) 
 
All other domains show 
random discrepancies with no 
statistical significance 
Paed:ASQ Poor agreement for 
summary (κ = 0.26) 
and poor agreement 
across all domains  
Statistically significant 
discordance is 
directional with PSA 
more likely to score 3 
(ρ=0.01) 
Random discrepancies for all 
domains with no statistical 
significance 
Paed: PEDS 
COMBINED 
Poor agreement for 
summary 
(κ= 0.28) 
Moderate agreement 
for domains of: 
SH (κ=0.65) 
FM (κ=0.53)  
SE (κ=0.48) 
Statistically significant 
discordance is 
directional with PSA 
more likely to score 3 
(ρ=0.03) 
Statistically significant 
discordance is directional  for 
Comm with PSA more likely 
to score 3 
(ρ=0.03) 
All other domains show 
random discrepancies with no 
statistical significance 
 
14.2.2 Comparison of rating 1, 2 & 3 
(Figure 8, Table 9) 
Concordance was significantly reduced when infants who had received a rating of 2 were included in the 
statistical analysis, particularly when comparing domain scores (κ < 0.04). Although reduced, for the summary 
scores agreement was still fair between the ASQ and PEDS COMBINED and still statistically significant (κ = 
0.58, ρ = 0.02). Poor agreement between the PSA and questionnaires for summary scores remained (κ < 0.26) 
and was still statistically significant for the ASQ (ρ = 0.02). ASQ remained the most sensitive screening tool 
overall, with PEDS COMBINED still the most sensitive for Comm concerns and the PSA the least likely to 
identify concerns. 
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Figure 8 Kappa comparison of Ratings 1,2 & 3  
(GM=Gross Motor, FM=Fine Motor, Comm = Communication, SH=Self Help, SE = Social Emotional) 
 
 
Table 9  Comparison of Rating of 1,2 & 3 
(GM=Gross Motor, FM=Fine Motor, Comm = Communication, SH=Self Help, SE = Social Emotional) 
 
 
 
0  0.2  0.4  0.6  0.8  1 
GM 
FM 
Com 
SH 
SE  
Summary  0.5815 
ASQ:PSA PEDS:PSA ASQ:PEDS 
Rating 1,2,3 Kappa Symmetry: Summary Symmetry: Domain 
ASQ: PEDS 
COMBINED 
Moderate 
agreement for 
summary  
(κ=0.58) 
Statistically significant 
discordance is directional 
with PEDS COMBINED 
being more likely to score 
a 3  
 (ρ = 0.03) 
Statisticallysignificant 
discordance is directional for FM 
& Comm. PEDS COMBINED 
more likely to score 3 for fine 
motor (ρ=0.04) and ASQ more 
likely to score a 3 for 
communication (ρ=0.00) 
PSA:ASQ Poor agreement for 
summary (κ=0.26) 
and across all 
domains 
Statistically significant 
discordance is directional 
with PSA more likely to 
score 3 (ρ=0.02) 
Random discrepancies with no 
statistical significance 
PSA: PEDS 
COMBINED 
Poor agreement for 
summary (κ=0.17) 
and across all 
domains 
Not significant but trend 
towards PSA more likely 
to score a 3 
Statistically significant 
discordance is directional for 
Comm (ρ=0.01) with PSA more 
likely to score 3 
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15 Discussion 
15.1 Response rate of caregivers and questionnaire bias 
The 57,5% return rate of questionnaires for this study may have resulted in non-respondant bias. According to 
the litrature, mail surveys have a mean response rate of 60%. This response is only slightly lower than the 60% 
and therefore indicates an acceptabe response rate (139). Of the 48 (42.5%) questionnaires not returned, non-
respondents were spread fairly equally throughout the different hospitals. An average of 35% of questionnaires 
were lost to follow-up per hospital cluster, decreasing the likelihood of one hospital cluster of biasing the results. 
(Figure 9) 
 
Figure 9 Percentage of Questionnaires Returned by Hospital  
(one hospital was left out as there was only one consent form received, which was returned - giving 100% return rate) 
 
 
The return rate rate in this study is also slightly higher than the response rate of 54% in the study reported by 
Hix-Small, Marks, Squires and Nickel (101) which looked at the implementation of the ASQ into a paediatric 
practice. In the Hix-Small study 13 demographic factors were assessed in non-respondents and non-respondent 
bias was found to be of no significance aside from two factors. A higher number of non-respondents were on 
Medicaid and were younger parents, suggesting that younger parents from lower income groups were less likely 
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 50 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 31 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forms 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to 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to 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Forms 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 72 
to respond. In the current study all subjects were recruited from the private health care sector, indicating a 
higher economic status, however information on actual economic status and maternal age at birth were not 
obtained.  
 
The fact that socio-economic data was not available in this study may be regarded as a limiting factor, but the 
ASQ and PEDS are recommended for use in infants from both high and low socio-economic groups (88, 101). 
Other studies have also reported that the accuracy of parental reporting on infants developmenal status is not 
influenced by sociodemographic factors or parental educational level (140, 141). The possibility that many of the 
non-respondents were younger mothers or from lower economic groups may make it less accurate to 
extrapolate the results from the study into lower SES groups in South Africa but does not affect the analysis of 
concordance between the screening methods of questionnaires that were returned. This study does not intend 
to address the validity of the questionnaires, but rather to identify how well they concur with each other and with 
the paediatrician’s subjective assessment. For this study therefore, each infant served as it’s own control and 
the agreement between the ASQ, PEDS COMBINED and PSA was analyzed at the level of the infant. Caregiver 
variables did not affect analysis.   
 
A further limitation of this study is that the two questionnaires were posted to the caregivers in one package. 
Answering the one questionnaire could potentially have influenced the answers to the second questionnaire. 
The caregivers motivation for filling in forms was to determine the developmental level of their infant and 
therefore there was no incentive to answer questions incorrectly on either questionnaire. In the study by Sices 
et.al. (112) where the ASQ and PEDS were also filled out on the same day the agreement between the tests 
was no different to that expected by chance, indicating that completion of questionnaires on the same day does 
not increase concordance.  
 
Further, the questionnaires are designed to be subjective and they ask different questions.  The format of the 
questions is also different for each questionnaire. As an example, Table 10 compares the GM item set from the 
ASQ and PEDS:DM questionnaires: 
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Table 10  Comparison of Gross Motor Items on ASQ and PEDS:DM 
Comparison of Gross Motor Items 
 ASQ – 6 month Questionnaire PEDS:DM – Assessment Level Version: 0-10 month items 
1 While on his back, does your baby lift his legs high 
enough to see his feet?  
Does your baby try to keep his or her head 
steady? 
2 When she is on her tummy, does your baby 
straighten both arms and push her whole chest off 
the bed or floor? 
Does your baby roll from her back to her 
side? 
3 Does your baby roll from his back to his tummy, 
getting both arms out from under him?  
If your baby is lying on her back, can she 
pass a toy from one hand to the other? 
4 When you put her on the floor, does your baby 
lean on her hands while sitting? (If she already sits 
up straight without leaning on her hands, check 
"yes" for this item.)  
Can your baby get around on hands and 
knees or by scooting on his or her bottom? 
5 If you hold both hands just to balance him, does 
your baby support his own weight while standing?  
 
6 Does your baby get into a crawling position by 
getting up on her hands and knees?  
 
 
15.2 Response rate of pediatricians 
The percentage of paediatricians returning a rating on their patients was 54%. A higher response rate (up to 
75%) may have been realized, but paediatricians were unable to give a PSA rating to 14 infants whose 
caregivers had returned questionnaires but not attended a six-month well-baby visit. A response rate of 54% is 
the same response rate as physician surveys published in the literature (139), and therefore taken as an 
acceptable response rate for this study.  
 
Because some paediatricians only returned one PSA, compared to others who returned up to six, data was re-
analyzed by randomly selecting one infant from each paediatrician who had returned more than one 
assessment. This was done to determine if a single paediatrician-cluster biased the results of this study.  The 
Kappa coefficient and test of symmetry was again used to determine the agreement between the 3 methods 
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with a sample size of 18 for the ASQ and 19 for the PEDS. The results were no different from the initial analysis 
indicating paediatrican-clusters did not bias the results. 
 
15.3 Interventions 
15.3.1 Physiotherapy 
In a study by Kalie et al. (21), 28% of 12-month-old infants qualified for and received physiotherapy for GM 
delays. In this study, although nearly 83% of paediatricians indicated that they would refer an infant under 12 
months with a mild, non-specific developmental delay for physiotherapy, only two of the 65 infants on the study 
were receiving physiotherapy, both of which had significant birth histories indicating cerebral palsy.  
 
In the study cohort, 4 (6%)  infants were identified by the paediatricians with GM concerns compared to 15 by 
the PEDS COMBINED and 15 by the ASQ (23% and 25% respectively). The detection rate for GM concerns by 
the questionnaires is very close to the percentage of 28% of children identified in the literature as requiring 
physiotherapy services in the first year following NICU care. The number of children requiring physiotherapy is 
likely to increase with increasing age as Reuner (10) found that by 17 years of age 55% of prematurely born 
children had required physiotherapy services. The rate of high-risk infants who will require physiotherapy is 
therefore greater than 23%, implying that questionnaires were unlikely to be over-detecting GM difficulties. Since 
most paediatricians indicated that they would refer infants under 12 months for physiotherapy but only 6% were 
identified with GM concerns, a large number of infants who could potentially have benefited were not referred to 
physiotherapy due to low detection rates by the paediatricians.  
 
15.3.2 Occupational Therapy and Speech Therapy 
Similar trends in infants who would have benefited from a referral to speech therapy or occupational therapy 
were noted in this study. Paediatricians identified 1 (1.5%) infant with communication difficulties, 2 (3%) infants 
with problem solving difficulties and 2 (3%) infants with FM difficulties. The questionnaires identified up to 14 
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(21.5%) communication delayed infants, 9 (14%) infants with problem-solving difficulties and 8 (12%) infants 
with FM difficulties. The literature shows that by 12 months, 16% - 32% of prematurely born infants received 
occupational therapy and 10% - 32% received speech therapy (21, 10). The detection rate of the questionnaires 
falls within the expected percentage of children likely to require occupational or speech therapy services as 
shown in the literature. This again highlights the low detection rates of paediatricians as well as the real 
possibility of referring infants early for intervention with the use of parent-administered screening tools.  
 
15.4 Referral Practices 
Paediatricians were asked to indicate if they commonly referred infants under 12 months of age with mild 
developmental delays to speech therapy, occupational therapy and physiotherapy. Less than half the 
paediatricians indicated they would refer infants to speech therapy and even less indicated they would refer to 
occupational therapy compared to more than 80% indicating that they would refer to physiotherapy. This was 
similar to the study conducted by Earls, Andrews and Hay (142) which found that providers were most 
comfortable referring infants with a clear motor skill issue and less certain of referral for problem solving issues 
and problems with personal social skills.  
 
The trend of paediatricians to refer more frequently to physiotherapy was described by Reuner et al. (10) in 
2009 as a gap between medical tradition which focuses on motor and neurological development and recent 
literature which highlights the impact of cognitive and neuropsychological deficits on developmental outcomes. 
In the current study, only one infant was identified by the paediatrician as having social-emotional concerns and 
this infant was diagnosed soon after birth with severe cerebral palsy. Difficulties identifying concerns in other 
domains were highlighted by one of the paediatricians in this study who commented that the infant was too 
young at 5 months corrected age to monitor areas other than gross motor.  
 
In infants under 12 months of age, many skills are still emerging and traditional domains of GM, FM and Comm 
are more likely to be identifiable. Similar to other studies (10, 80, 142), in this study GM concerns were the most 
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frequently identified concerns by all three screening methods (ASQ, PEDS COMBINED and PSA), followed by 
communication concerns (Figure 5). The parent-administered questionnaires also identified 11% of SE concerns 
and 14% of infants with PS difficulties however, indicating that it is possible to identify and monitor more subtle 
developmental areas of cognition and emotional development in young infants with the use of parent-
administered questionnaires.  
 
15.5 Domains of Development 
Some caution should be exercised when looking at specific developmental domains for an infant however, as 
especially at these early ages development in the different domains is interrelated and difficult to isolate. This 
can be seen in the choice of items chosen to represent specific domains by the different questionnaires. For 
example, PEDS:DM classifies the following question under the GM domain: “If your baby is lying on her back, 
can she pass a toy from one hand to the other?”. In the ASQ a very similar question, “does your baby pass a toy 
from one hand to the other?” is classified under the PS domain. 
 
In both the ASQ and PEDS COMBINED, a rating of 1 in the SE domain was always associated with a rating of 1 
or 2 in the GM domain, highlighting the inter-relationship between the domains. As an example, in the ASQ the 
question, “When on his back, does your baby put his foot in his mouth?” is classified as a SE domain, but is 
highly dependent on gross motor skills. A case study from the cohort is given below to illustrate this point.  
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Infant 131B was born at 27 weeks gestation weighing 1040g. The child was ventilated for approximately 6 
weeks and spent 108 days in the NICU suffering a Grade III Intraventricular heamorrhage, grade IV ROP and 
severe gastro-oesophageal reflux. The mother reported the infant underwent the following procedures whilst still 
in the NICU: VP shunt, laser for ROP, Nissan procedure and gastrostomy tube insertion. 
 
 From this history, the infant can be classified as high risk for developmental difficulties in all domains. Other 
difficulties also need to be considered including possible visual problems from ROP and feeding difficulties or 
oral aversion from severe reflux, which may affect normal infant behavioural responses and complicate the 
presentation. 
 
The PEDS COMBINED and ASQ were completed by the mother when the infant was 6.5 months corrected age. 
This infant passed all domain items on the PEDS COMBINED except for RL. On the ASQ, the infant failed the 
GM and PS domain and scored as high-risk in the SE domain.  
 
Table 11 illustrates the items failed in the two tests. Domains in which difficulties could possibly have resulted in 
failure of the items are checked. For example, the infant not holding out arms when mom says “come here” 
could be due to poor control of the trunk or shoulder girdle (GM), difficulty coordinating bilateral arms (FM), not 
recognizing the phrase or intonation (RL), not responding appropriately to social interactions (SE) or not yet 
understanding actions and consequences (PS). Possible other issues for failure of this item include an 
undetected hearing loss resulting in the infant not responding to speech. To determine which of these are 
actually responsible for the item failure requires a more in-depth assessment.   
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Table 11  Domains involved in failed items on ASQ and PEDS:DM 
Domains possibly involved in failed items 
 GM FM RL EL SE PS Summary 
PEDS Rating 3 3 1 3 3 3 1 
Items failed GM FM RL EL SE PS Other 
Not excited to see breast or bottle       
 - Vision, oral 
aversion, lack of feeding 
experience due to 
gastrostomy tube 
Not holding out arms when mom says “come here”        - Auditory 
 GM FM RL EL SE PS Summary 
ASQ Rating 1 3 3 2 1 1 
Items failed GM FM RL EL SE PS Other 
Not prop-sitting, standing with support or pushing 
into 4-point-kneeling 
       
Not smiling in mirror        - Vision 
Not getting hands to feet or feet to mouth        
Not passing toys from one hand to the other        
Not playing by banging toys        
Not reaching with bilateral hands        
 
The ASQ rates GM and PS as 1, indicating a referral to physiotherapy or occupational therapy. The PEDS 
COMBINED rates RL as 1, indicating a referral to speech therapy or audiology. There is therefore poor 
agreement between the two questionnaires. If summary scores are taken into account however, both 
questionnaires have a rating of 1 and identify this child as requiring further assessment. To account for the 
complexity of developmental domains and their influence on development, as well as other environmental or 
genetic influences, it is essential that this next phase of developmental assessment be completed by 
practitioners or EI teams who are experienced in childhood development (4, 51). 
 
The complexity of each milestone and the variety of skills that contribute to an items success makes it difficult to 
limit items to one domain. This may explain why summary scores for the ASQ showed excellent agreement with 
the summary scores for the PEDS COMBINED (k = 0.82); but domain scores showed only moderate agreement 
between the two questionnaires (k < 0.53).  
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15.6 Comparison of the ASQ & PEDS COMBINED 
15.6.1 Summary Ratings 
Differences in summary recommendation from the ASQ and PEDS COMBINED were analyzed. Statistical 
analysis revealed that although there was excellent agreement for summaries of the two questionnaires (90.7%, 
κ = 0.82, ρ < 0.05), if they disagreed the trend was l for the ASQ to be more sensitive than the PEDS.  
 
When the PEDS COMBINED failed an infant (rating 1), the ASQ was likely to rate the infant as high risk (rating 
2), indicating developmental concerns even though the infant did not fail the ASQ. Instructions in the ASQ 
User’s Guide” suggest that if several areas of development receive scores that are low but not below the cutoff 
point, the child may need to be referred for assessment (88). Scoring in this manner was not used for this study 
as the recommendations were slightly vague and subjective. Four of the five infants who scored a 1 for the 
PEDS did however have more than one domain with a rating of 2 on the ASQ and could therefore have possibly 
received a summary rating of 1 for the ASQ also. This indicates that when the infant failed the PEDS 
COMBINED, they were very likely to show concerning development on the ASQ.  
 
There were four infants that received a rating of 1 on the ASQ summary and a rating of 3 on the PEDS 
COMBINED summary. This sample size was too small to reveal any patterns between these discrepancies but 
show a trend for the ASQ to be more sensitive to developmental delays that the PEDS in this cohort. The 
opposite of this was found in the study by Sices et.al. (112) where the PEDS identified more children than the 
ASQ with developmental concerns. This difference was also not significant however and further investigation 
into the function of these two questionnaires is different settings may be beneficial in this regard. 
 
15.6.2 Domain Ratings 
Comparison of domain discrepancies did reveal a statistically significant pattern of disagreement between these 
two questionnaires for the domain of Comm. Discordance was in the direction of the ASQ scoring a 3 when the 
PEDS COMBINED scored a 1 (ρ = 0.01). This may be explained by the fact that the ASQ combines receptive 
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and expressive language into one domain, whilst the PEDS COMBINED separates these two components of 
language into two separate domains (RL and EL). The value of separating these two domains of development 
can be shown by using an example of one of the infants in this study.  
 
At 10 months corrected age, this infant was given a rating of 1 for the communication domain 
for the PEDS COMBINED as he failed the following RL items.  
“When you say your baby’s name does he or she stop and look at you?” 
“When you say things like, “Where’s your bottle?” does your baby look around for his or her 
bottle?” 
He was given a rating of 3 for the ASQ communication domain, but when individual items 
were analyzed, he had failed both the receptive language items: 
“If you ask her to, does your baby play at least one nursery game even if you don’t show her 
the activity yourself (eg. “Peekaboo)” 
“Does your baby follow one simple command, such as “come here”, “give it to me” without 
your using gestures?” 
The remaining four questions under the communication domain were passed, but related to 
expressive language and this pulled the infant’s score up, resulting in a pass for this domain 
on the ASQ.  
 
The ASQ was less sensitive than the PEDS COMBINED in detecting delays in communication, with the PEDS 
COMBINED detecting 15 infants with communication delays compared to 3 by the ASQ. The study by Sices 
et.al. (112) also identified the Comm domain as the most likely domain to be discordant between the two 
screens. The population group was older in the Sices et.al. study, with a mean age of 17.6 months (SD: 6.1 
months), indicating that the discrepancies in the Comm domain persisted into the older age groups. The 
discrepancy in the current study between ratings in the Comm domain did not cause significant disagreement in 
the summary scores of the ASQ and PEDS COMBINED however, as all of the infants who passed the ASQ 
Comm domain failed in another ASQ domain or scored as high risk (rating 2) in at least two other ASQ domains.  
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The GM domain for the PEDS is another area where individual domains are analysed differently by the two 
questionnaires. The PEDS does not flag GM concerns as predictive of developmental concerns until 3-years of 
age. The reason for this is explained by Glascoe (143). The author points out that the original design of the 
PEDS was to identify children for special education. In the USA children with physical impairment only qualify for 
placement in special education when there are other developmental concerns and therefore predictive value of 
other parental concerns are given more weight than gross motor concerns. This poor ability to identify GM 
concerns before 3-years of age is addressed with the PEDS COMBINED however, which provides age-
equivalent scores and percentage delays for all domains and resulted in similar number of children on this study 
being identified for GM concerns using either the ASQ or PEDS COMBINED with moderate agreement between 
the two screens (k=0.53). (102, 104).  
 
15.6.3 Detection Rates 
Use of the PEDS COMBINED also addresses problems found with using PEDS alone in a high-risk population 
group. Pritchard, Colditz and Beller (144) found that caregivers whose children were already receiving EI may 
have answered “no” to the questions on the PEDS regarding their concerns about their child’s needs because 
these were already being addressed. This resulted in a high false-negative rate in their study on prematurely 
born infants using just the PEDS. In the current study, adding the PEDS:DM assessment level version, which is 
specifically recommended for following up infants requiring NICU care (104), resulted in a high rate of positive 
screen and a similar percentage of infants being identified by the PEDS COMBINED (42%) and ASQ (40%) (κ = 
0.82). The similarity in identification rate and agreement between the PEDS COMBINED and ASQ implies that 
the PEDS COMBINED is an appropriate tool for use in this population since the ASQ was originally designed for 
following up NICU infants and has been used with success in this population group (83, 91, 92, 93).  
 
In a comparison of the ASQ and PEDS conducted by Sices et.al.(112) in 2009, the ASQ identified 27% of 
children at risk for developmental delay, whereas the PEDS identified 37%. Although the percentage difference 
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of children identified was not statistically different, the agreement between the ASQ and PEDS was only 
moderate and not different from that expected by chance (κ = 0.24). The difference between the current study 
and the study by Sices et. al., is the addition of the PEDS:DM. Using the PEDS COMBINED resulted in excellent 
agreement between the tests (κ = 0.82) with the PEDS identifying 37.97% of the infants as requiring further 
assessment and the ASQ identifying 36.36% from the cohort. The PEDS COMBINED therefore seems to 
address issues of parental interpretation and decreased GM sensitivity, resulting in excellent overall agreement 
between the ASQ and PEDS COMBINED and significantly decreasing discordance.  
 
15.6.4 Practicalities when using the ASQ and PEDS COMBINED 
There is some discussion as to which questionnaire is more appropriate to use in a particular setting. The 
decision about which of these tools to use has primarily focused on provider choice (56, 112). In this study the 
ASQ was easier to learn, use and score. It did not require additional score sheet like the PEDS COMBINED and 
the information summary for each questionnaire contained the cut-off points in an easy to use scoring system 
(Appendix 18.4 -18.6). The PEDS:DM assessment level version was more appropriate for screening infants by 
mail however as the continuous item levels meant that forms were meaningful regardless of the age of the infant 
when it was completed. When using the ASQ for this study, if caregivers did not complete the questionnaire at 
the right time, scoring became problematic. Reasons for this include forms that were received late due to the 
poor postal system, caregivers filling in forms late and one form where the caregiver completed the form too 
early, resulting in concerns that were no longer found when they filled the form in again at the correct time.  
 
Another consideration for choosing questionnaires to use in the clinical setting or for research is the support by 
the authors of the questionnaires. The author of the PEDS COMBINED was always responsive to questions 
about the use and application of the tool. In comparison, it was very difficult to get a response to questions 
regarding the ASQ from the publishers as they did not respond to any questions other than those related to the 
copyright laws. 
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15.7 Identification of developmental delay  
15.7.1 Comparison of three screening methods 
The literature indicates that the percentage of children from a neonatal intensive care that would benefit from EI 
is between 30% - 70%, with an average of 42% needing educational support, as compared to 10% - 18% in the 
general population(10, 16, 26). In this study, the ASQ identified 40% and the PEDS COMBINED identified 42% 
of NICU infants as developmentally delayed, in-line with the expected prevalence of developmental delay of 
high-risk infants in the literature. The paediatricians identified only 6% of the NICU infants as developmentally 
delayed, well below the expected prevalence for infants requiring NICU care and even below the percentage 
expected in the general population with no risk. Other studies have also shown under detection of 
developmental delay when health care practitioners do not use standardized screening methods (62, 80) (Table 
12). 
Table 12 Comparison of ASQ, PEDS COMBINED and PSA screens 
PEDS:ASQ Questionnaires (n) PSA pass (n) PSA fail (n) Lost to follow-up (n) 
Pass:Pass 19 12 0 1 
Pass:Fail 4 1 0 1 
Fail:Pass 0 0 0 0 
Fail:Fail 20 6 2 6 
 
Of the infants in this cohort, 13% had not been to their paediatrician for a developmental assessment in more 
than 4 months and had no future appointments planned. For example, one mom reported that she would not be 
seeing her paediatrician unless her baby was sick as her paediatrician was too far away. This infant received a 
rating of 1 for GM concerns on the PEDS and a rating of 2 for GM concerns on the ASQ. Another infant had not 
seen their paediatrician due to financial constraints since the birth. This infant received a rating of 1 for GM, FM 
and SH skills on the PEDS (the ASQ was not completed). These examples highlight the benefit of a cost-
effective systematic screening programme to identify those infants that may otherwise be lost to follow-up. They 
also highlight the fact that parental compliance rates affect the success of EI (17). 
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15.7.2 Accuracy of detection 
The current study did not include a diagnostic measure to determine the accuracy of the questionnaires in 
detecting developmental delay. Other studies have looked at the accuracy and validity of the questionnaires in 
comparison to “gold standard” diagnostic measures and have found acceptable psychometric properties (88, 
102).  
 
The accuracy of the ASQ in a clinical setting was examined in a retrospective study by Marks, Hix-Small and 
Clark (17) in 2009. The authors compared the accuracy of paediatricians’ screening practices to the ASQ in the 
referral of infants to EI and childhood special education. In their study nine infants were identified as age 
appropriate between 12 and 24 months by the board-certified paediatricans but as developmentally delayed by 
the ASQ. Only one of these nine infants went on to be assessed as not requiring either early intervention or 
early childhood special education by 60 months. When the authors looked retrospectively at children who were 
appropriately enrolled in intervention services, 52.9% of the earlier referrals were directly as a result of the use 
of the ASQ. The authors concluded that the ASQ was correct to capture a higher percentage of concerns and 
recommended that only children who are already enrolled in intervention programmes should bypass 
developmental screening.  
 
Statistical analysis between the ASQ:PSA and the PSA:PEDS COMBINED show that the agreement between 
the paediatricians and the questionnaires was poor and statistically less than expected by chance (κ = 0.26 and 
κ = 0.28 respectively with p<0.05). In contrast, the agreement between the two questionnaires was excellent 
and statistically greater than expected by chance (κ = 0.82, ρ < 0.05). It is likely that the questionnaires were 
correct in identifying a significantly higher number of infants as developmentally at risk and the under-detection 
of developmental difficulties by the PSA may have resulted in many of the infants not being referred for EI at a 
time when they could have had substantial benefit.  
 
In the study by Marks et al (17), paediatricians and the ASQ were significantly more likely to agree on 
developmental status in infants that were full-term than infants that were preterm. The authors concluded that 
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paediatricians probably experienced exaggerated difficulties identifying delayed development in lower risk, 
mostly late preterm infants. This can be related to the current study where the average gestational age of the 
infants was 34 weeks (SD = 2) and the average birth weight was greater than 1500g. Many of the infants from 
the study are therefore classified as lower-risk NICU infants and possibly more difficult to accurately assess for 
developmental difficulties without the use of a developmental screening tool. 
 
15.8 Summary 
This study has found that the use of both the ASQ and PEDS COMBINED was feasible in the South African 
private health care context. The questionnaires’ rate of detection of developmental delay in a high-risk infant 
population group was in line with published international literature of expected rates for this population and the 
questionnaires were able to appropriately identify the same infants as developmentally delayed. The 
paediatricians identified a much lower rate of infants requiring further developmental assessment well below the 
expected rate of infants at-risk for developmental delay. 
 
Olusanya stated that until those ‘who are likely to be consulted first by caregivers are convinced or even aware 
of the value of early detection and intervention, only minimal progress will be realised’ (145). Considering the 
low rate of detection and lack of knowledge or use of parent-administered questionnaires by paediatricians in 
this study, this is an area that needs to be addressed. The need for improving knowledge and use of systematic 
developmental screening in South Africa with affordable and standardized tools is essential. 
 
South African children face many challenges and should not be unnecessarily disadvantaged or deprived of EI 
opportunities simply due to under detection. Screening and monitoring developmental difficulties using parent-
administered questionnaires is a feasible first step in early identification of developmental delay and a critical 
requirement for implementing and assessing early intervention services. 
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16 Limitations and Recommendations 
16.1 Further follow‐up studies on this cohort 
This study looked at a select group of paediatricians and infants at-risk for developmental delay in the private 
health care sector in the southern region of Gauteng, South Africa. Optimal screening requires several screens 
at different time points. Infants in this study only received one screening each and further screening of these 
infants would have been useful in identifying the infants developmental trajectories and helpful in further 
identifying strengths and weaknesses in the performance of the ASQ and PEDS COMBINED.  
 
It would also be helpful to assess the type of EI services available for these infants in the South African context 
as well as their pattern of usage, and the efficacy of the EI services.  Studies documenting the long-term 
academic requirements of these infants who received NICU care in the private health care sector of South Africa 
would be valuable in comparing South African outcomes to those of other countries. 
 
It would be beneficial to study the impact of identification and referral rates of paediatricians from this cohort 
following the introduction of a more formal screening programme into their practices. 
 
16.2 Bias and Demographics 
As discussed in section 15.1, the bias of non-respondents and the influence of completing both questionnaires 
at the same time could not be determined in this study. This may be addressed in future studies by identifying 
demographic variables and by asking the two main caregivers to fill in different questionnaires at the same time, 
or by changing the order of completion of the questionnaires in two homogenous groups of caregivers. 
Determining the demographics of future respondents and non-respondents will be beneficial in identifying which 
population groups would benefit from postal questionnaires and which would require screening at clinician visits. 
 
Both questionnaires were scored by the researcher, introducing a possible bias. The questionnaires are 
designed to be subjectively scored according to the parent’s concerns and are not open to interpretation by the 
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person scoring the tests however, decreasing the likelihood of this affecting results. Being blinded to the result 
of the other questionnaire would never the less further decrease the possibility of bias.  
 
16.3 The South African Population 
A limitation of this study is a small cohort that is not representative of the greater South African population in the 
public health sectors or in other regions.  
 
Studies on the long-term outcomes of infants who graduated from an NICU in South African are needed.  
Information on the use of EI services in both the public and private health sector would also be beneficial, as 
well as information on the performance of existing early intervention programmes in terms of screening methods 
used, success in detecting developmental delay and efficacy of the services. 
 
This information would assist in determining the impact of introducing more formal screening practices into these 
sectors and could also be used towards addressing the ethical considerations of ensuring intervention is 
available before implementing screening programmes. 
 
16.4 Parent‐administered Questionnaires 
It has been shown in this literature review that parent-administered screening tools have been used in LAMI 
countries including South Africa. Validation studies in the private and public sectors of South Africa of these 
questionnaires has not yet occurred and be beneficial, particularly in the older age groups where the 
questionnaires are more likely to be influenced by different cultures.   
 
This study looked only at the 6-month-old age group. Both the ASQ and PEDS COMBINED are recommended 
from 0 to 8 years of age and therefore investigation into the functioning of these questionnaires at different age 
groups and over different time frames is needed.  
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The practicalities and costs of using these parent-administered screening tools in different South African 
contextsalso  needs further investigation. 
 
The under-detection of developmental delay found in this study, together with the dearth of information on 
developmental screening practices and EI in South Africa highlights areas for further research. The use of 
parent-administered questionnaires for this purpose seems feasible and would play an important role in 
influencing policies to improve services for South African children.  
17 Conclusion 
This study has proved the hypotheses listed under Rationale and Research Questions in chapter 12: 
1. The number of infants identified with developmental concerns by the  PEDS COMBINED and ASQ was 
greater than that identified by the PSA. 
2. The ASQ and PEDS COMBINED showed good agreement, better than that expected by chance 
3. The PSA showed poor agreement with both the ASQ and PEDS COMBINED, less than expected by 
chance 
4. Standardised parent-completed questionnaires are not routinely used by paediatricians in private 
practice in the southern Gauteng region of South Africa at present. 
 
The excellent agreement between the two questionnaires indicates that these tools are effective in identifying 
children who require further developmental assessment. In contrast, the poor agreement of the paediatricians’ 
subjective assessment with both questionnaires identifies a trend in paediatric private health care that could be 
improved and highlights the benefit of using these questionnaires to increase the early detection of children with 
developmental delay to improve early intervention and outcomes. 
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18 Appendix 
18.1 Ethical Clearance 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18.2 Information and Consent Forms  
 
18.2.1 Hospital 
 91 
Early Intervention Study For NICU Babies  
Hospital Manager / Superintendent Consent Form 
 
Dear  
 
Hello, my name is Mindy Silva. I am a paediatric physiotherapist currently completing my masters degree in 
child health and neurodevelopment.  I would like to invite your hospital to participate in my study, which will 
investigate the use of a parent questionnaire in detecting babies who would benefit from early intervention.  
 
The rationale for the study is my belief that Standardised screening questionnaires would be a simple and cost-
effective tool to introduce in both the private and public sectors in South Africa in order to facilitate timeous 
referrals for early intervention. Age-specific, standardised, parental screening questionnaires are easy to 
administer and cost effective, making them practical to implement at regular intervals.  
 
Before leaving the NICU, parents will be invited to participate in the study by a letter (copy attached). When their 
baby is between 4 and 6 months corrected age, they will complete a parental screening questionnaire which will 
be scored by myself. Following this, when these babies next see their chosen paediatrician, I will contact the 
paediatrician to ask if they have identified any developmental concerns. Their concerns will then be correlated 
with the concerns identified by the parent-completed questionnaire. 
 
All information will be completely confidential. Individual hospitals will not be identified. Babies will be assigned a 
number, and the baby’s name will not appear on the questionnaire, nor on the feedback response from the 
paediatrician. Similarly, each paediatrician participating in the study will be assigned a letter. The paediatrician 
will not be asked for any information except that related to developmental concerns. Names, numbers and 
letters will be kept on a secure data base which is password protected and will be kept separate from the 
information generated by the completion of the forms and the telephonic report from the paediatrician.  The 
study has been approved by the Human Research Ethics Committee (Medical)- Protocol M070416 
 
Participating in this study will potentially assist in the introduction of a screening tool into the South African 
context, which may help many children in the future to gain from the benefits of receiving the intervention they 
need. 
 
I am therefore requesting your permission to approach parents of babies being cared for in your NICU to ask 
them to participate in this study. You may of course withdraw your consent at anytime and discontinue 
participation without any reason or penalty. 
 
Thank you for taking the time to read this. Please complete the attached form.  
 
If you have any questions about this letter or the study, please contact me at CentaPaeds Therapy centre on 
011-453-2624 or e-mail me at mindy@iburst.co.za.  
 
 
Sincerely 
 
Mindy Silva 
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Early Intervention Study For NICU Babies  
Hospital Manager’ / Superintendent Consent Form 
 
Thank you for considering your participation in this study on the use of parent 
questionnaires to detect babies who would benefit from early intervention. Please complete 
the information below, delete which ever option is not applicable and fax to 011 453-2624. 
  
 
I ________________ (name) do / do not (delete whichever is not applicable) give permission for  
__________________(hospital name) to participate in this study. I have read and understood 
the attached letter. I understand that I may withdraw my consent at anytime and discontinue 
participation without any reason or penalty.  
 
___________  _____________ 
Sign   Date 
 
Surname _______________ Name __________________ 
 
Hospital ___________________ 
 
 
 
PLEASE RETURN FORM BY FAX: 011 453-2624 
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18.2.2 Caregivers 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Parent’s Information Letter 
 
Dear Parents or Gaurdian 
 
Hello, my name is Mindy Silva. I am a paediatric physiotherapist currently completing my masters 
degree in child health and neurodevelopment.  I would like to invite you to participate in my study, 
which will investigate the use of a parent questionnaire in detecting babies who would benefit from 
early intervention.  
 
Professional organisations (such as The Committee on Children with Disabilities of the American 
Academy of Pediatrics) recommend screening of all healthy infants and children for developmental 
delay. The obvious benefit in this can be found in studies that have shown that a child will benefit 
more from intervention programmes that are begun as early as possible. Parent questionnaires are 
being used overseas as routine methods of screening infants. The purpose of this study is to introduce 
parent questionnaires into the South African paediatrician’s office and to compare the ability of these 
questionnaires to that of the paediatrician in detecting developmental concerns. 
 
If you agree to participate in the study you will be mailed 2 short questionnaires and a form 
requesting updated contact details and health information, which can be completed in your own home 
when your baby is between 4 and 7 months corrected age. The questionnaire will take you 
approximately 5 minutes each and consists of short questions about your baby’s developmental 
milestones and concerns that you might have about your baby’s development. You will then need to 
post this back to me. Cost of postage will be covered by myself. I will also need your consent to 
allow your paediatrician to give me a telephonic report on your baby’s development following your 
routine check-up between the 4th and 7th month corrected age. 
 
All information will be completely confidential. You will be assigned a number so that neither your 
name, nor your baby’s name, appears on the questionnaire, or feedback response from the 
paediatrician. The paediatrician will not be asked for any information except that related to 
developmental concerns. Names and numbers will be kept on a secure data base which is password 
protected and will be kept separate from the information generated by your completion of the forms, 
and the telephonic report from your paediatrician. The study has been approved by the Human 
Research Ethics Committee (Medical)- Protocol M070416 
 
By participating in the study, you will benefit from a holistic screening of your baby’s development. 
You will also be given numbers to contact in the event of any concerns or anxiety that you may have 
as a result of participating in this study. Participating in this study will potentially assist in the 
introduction of a screening tool in South Africa, which may help many babies to gain from the 
benefits of receiving the intervention they need. 
 
Signing and filling in the attached form indicates that you have read and understood all the 
information provided above; and that you agree to participate willingly. You may withdraw your 
consent at anytime and discontinue participation without any reason or penalty. 
 
Thank you for taking the time to read this. If you have any questions about this letter or the study, 
please contact me at CentaPaeds Therapy centre on 011-453-2624 or e-mail me at 
mindy@iburst.co.za. 
 
 
Sincerely 
 
Mindy Silva 
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Parent’s or Guardian’s Consent Form 
Thank you  for considering your participation in this study on the use of parent 
questionnaires to detect babies who would benefit from early intervention. Please complete 
the information below and delete which ever option is not applicable. 
 
I ________________ parent / legal guardian of ____________ agree / don’t agree to willingly 
participate in this study. I further give consent for you to contact my baby’s paediatrician for 
information on his/her development. I have read and understood the attached letter. I understand that 
I may withdraw my consent at anytime and discontinue participation without any reason or penalty.  
 
___________  _____________ 
Sign   Date 
 
Surname _______________ Name __________________ 
 
Baby’s name ________________ Paediatrician ________________ 
 
Baby’s date of birth ______________ expected date of birth ______________ 
 
Baby’s birth weight  _____________ 
 
Name of hospital where baby was born _____________________ 
 
Name of hospital where baby was in NICU _____________________ 
 
How long did your baby stay in the NICU _____________  
 
Reason for NICU stay ___________________________________________________ 
 
How many days was your baby ventilated ______________ 
 
Operations _________________________________________________________ 
 
Complications _________________________________________________________ 
 
Contact Details 
 Mother’s Details Father’s Details 
Name 
 
  
Residential Address 
Postal 
Home tel 
 
  
Work tel. 
 
  
Cell no. 
 
  
Fax no. 
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18.2.3 Paediatrician 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Early Intervention Study For NICU Infants 
Dear Doctor 
 
Thank you for taking the time to read this information. My name is Mindy Silva. I am 
currently completing my masters degree in child health and neurodevelopment.  I would like 
to invite you to participate in my study, which will investigate the use of parent 
questionnaires in detecting babies who would benefit from early intervention.  
 
The rationale for the study is that standardised, parent-administered screening 
questionnaires would be a simple and feasable tool to introduce in both the private and 
public sectors in South Africa, in order to facilitate developmental monitoring. These 
parental screening questionnaires are easy to administer and cost effective, making them 
practical to implement at regular intervals.   
 
Parents on this study have babies who have required more than 3 days NICU care in any 
one of the private hospitals in the Southern Gauteng area. They have filled in parent-
administered screening questionnaires regarding their baby’s neurodevelopment, which 
they have received by post, fax or e-mail.  They have also given consent for me to contact 
you in order to obtain a subjective report on their baby’s neurodevelopmental status.  
 
Details regarding the baby’s neurodevelopment are not required, only wheather or not there 
are concerns in any of the developmental domains. You will not be asked for any 
information other than to indicate if the baby is doing well or requires a more in-depth 
assessment or closer monitoring (A sample form is included on page 4). Although I do not 
require any detailed information, any comments you make will be valuable to me in 
interpreting my data. A once-off short questionnaire regarding your knowledge of parent-
administered questionniares is provided  on page 3 and I would appreciate your input on 
this also.  
 
You and your patient’s details will remain anonymous and confidential. Information will be 
kept on a secure data base. The study has been approved by the Human Research Ethics 
Committee (Medical)- Protocol M070416 
 
Participating in this study will potentially assist in the introduction of a screening tool into the 
South African context, which may help many children in the future to gain from the benefits 
of receiving the intervention they need. 
 
Signing and filling in the attached form on page 2 indicates that you have read and 
understood all the information provided above; and that you agree to participate willingly. 
You may withdraw your consent at anytime and discontinue participation without any reason 
or penalty. 
 
Thank you for taking the time to read this. If you have any questions about this letter or the 
study, please contact me at CentaPaeds Therapy centre on 011-453-2624 or e-mail me at 
mindysilva1@gmail.com 
 
Sincerely 
Mindy Silva 
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Doctors Consent Form 
Thank you for considering your participation in this study on the use of parent-administered 
questionnaires to detect babies who would benefit from early intervention. Please complete 
the information below and delete whichever option is not applicable. 
 
 
I ________________ (name) agree / do not agree to willingly participate in this study. I have 
read and understood the attached letter. I understand that I may withdraw my consent at 
anytime and discontinue participation without any reason or penalty.  
 
___________  _____________ 
Sign   Date 
 
Surname _______________ Name __________________ 
 
Address of rooms 1 
 
Address of rooms 2 
 
Telephone number rooms 1 
 
Telephone number rooms 2 
 
Please make a note of preferred times and numbers that I can contact you on  
 
___________________________________________ 
 
Would you prefer to give information by telephone, e-mail or fax? (circle preferred choice) 
 
e-mail: ______________________   Fax: _____________________ 
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18.3 Caregivers Pack 
18.3.1 Information Sheet 
18.3.2 Details Update Form 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Please fill out this form, even if you have already done one previously 
 
Initial Parent’s or Guardian’s Consent Form 
Thank you  for considering your participation in this study on the use of parent 
questionnaires to detect babies who would benefit from early intervention. Please complete 
the information below and delete which ever option is not applicable. 
Please type in coloured areas 
 
 
I parent / legal guardian of agree / don’t agree to willingly 
participate in this study. I further give consent for you to contact my baby’s paediatrician for 
information on his/her development. I have read and understood the attached letter. I understand that 
I may withdraw my consent at anytime and discontinue participation without any reason or penalty.  
 
   
   Date 
 
Surname   Name  
Baby’s name   Paediatrician  
Baby’s date of birth  Expected date of birth  
Baby’s birth weight  Name of hospital where 
baby was born   
 
Name of hospital where 
baby was in NICU  
 How long did your baby 
stay in the NICU 
 
Reason for NICU stay   
How many days was your baby ventilated    
Operations    
Complications   
   
Contact Details 
 Mother’s Details Father’s Details 
Name   
Residential  Address 
Postal  
Home tel   
Work tel.   
Cell no.   
Fax no.   
e-mail   
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Early Intervention Study For NICU Babies  
Details update form – Please complete 
Please type in coloured areas 
Use as much space as you need  
 
Baby’s name:    
Date PEDS:DM assessment level booklet was 
filled in 
 
Date PEDS response form was filled in: :  
Date of last paediatrician’s visit  
Date of next paediatrician’s visit:   
Name of paediatrician    
Telephone no. of paediatrician   
 
 Total number of days your baby was in NICU  Total number of days ventilated  
 Please make a note of any serious illnesses or operations your baby has had since leaving the NICU: 
 
 Has your baby received an assessment, or been referred for an assessment, to a  
 therapist or specialist due to concerns about development?  Mark with an X 
 Yes  No 
 Please specify: 
 
 
Developmental screening should be an ongoing process. Can I send you similar 
forms to monitor your baby’s development in the future? 
 Yes  No 
 
FOR OFFICE USE – DO NOT COMPLETE  
1 – Refer 2 – Monitor 3 – No concerns  
 Gross 
motor 
Self 
help 
Fine motor Expressive Receptive Social-emotional 
PEDS/PEDS:DM       
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18.3.3 PEDS COMBINED Sample 
 
Glascoe FP. Parents' Evaluation of Developmental Status. Nashville, TN: Ellsworth & Vandermeer Press LLC, 
2006 www.pedstest.com 
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18.3.4 ASQ Sample 
 
Bricker D, Squires J. Ages and Stages Questionnaires. A Parent-Completed Child-Monitoring System 
Second Edition. Paul H. Brookes Publishing Co. Baltimore, Maryland 1999
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18.4 Score Form PEDS 
 
Glascoe FP. Parents' Evaluation of Developmental Status. Nashville, TN: Ellsworth & Vandermeer Press LLC, 
2006 www.pedstest.com 
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18.5 Score Form PEDS:DM 
 
 
© Glascoe FP, Robertshaw NS. Parents' Evaluation of Developmental Status: Developmental Milestones 
(PEDS:DM). Nashville, Tennessee: Ellsworth & Vandermeer Press, LLC 1013 Austin Court, Nolensville, 
Tennessee 37134, (October, 2006)
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18.6 Score Form ASQ 
Squires J, Bricker D, Potter L.  Ages and Stages Questionnaires User's Guide. 2nd ed.  Baltimore: Paul Brookes 
Publishing, 1999.
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18.7 Doctors Pack 
18.7.1 Short Questionnaire 
18.7.2 PSA 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Knowledge And Use Of Parent-Completed Screening Questionnaires 
 
1. Do you commonly refer babies under 12 months old with a non-specific, mild developmental 
delay for any of the following: 
a. Physiotherapy 
b. Occupational therapy 
c. Speech therapy 
 
2. What do you normally base your referral on?  
a. Specific guide lines 
b. Clinical judgement and experience 
 
3. Do you think the parents in your practice are able to identify developmental delays in their 
babies? Yes / No 
 
4. Do you know about parent administered questionnaires for developmental screening? Yes 
/ No 
a. If yes, can you name any? 
List _____________________________ 
 _____________________________ 
 _____________________________ 
 
5. Have you ever used them in your practice? Yes / No 
a. If yes, which ones have you used?  
List _____________________________ 
 _____________________________ 
 _____________________________ 
 
b. What was your experience with it?  
i. Beneficial 
ii. Not beneficial  Expand 
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PSA 
 
Baby’s name:      Date: 
Date of last appointment: 
Mark an X in the appropriate column for EACH point.( 1 – 6).  
Make any relevant comments underneath each point 
NB!  Please indicate if there is any area of development which you will be monitoring more 
closely than usual 
 Delayed - Refer for in 
depth assessment / 
intervention 
Concerned :–  
monitor carefully 
Not concerned at this time 
1. Fine motor 
 
   
Comments 
 
 
 
2. Self help 
 
   
Comments 
 
 
 
3. Receptive 
 
   
Comments 
 
 
 
4. Expressive 
 
   
Comments 
 
 
 
5. Gross motor 
 
   
Comments 
 
 
 
6. Social 
emotional 
   
Comments 
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18.7.3 Examples of Feedback Forms 
18.7.3.1 Paediatrician 
 
October 10, 2008 
 
Dear Klaas, 
 
Cortez Schoerie, , has been a participant in research on the early  detection of developmental delay 
using  parent administered screening questionnaires at age 6 months corrected (the PEDS;PEDS:DM 
and Ages & Stages). These are screening tools recommended by the American Academy of 
Pediatrics.  
Analysis of the forms show that he is falling significantly below his age level for a gross motor skills 
development and has several other areas of concern including receptive languages skills. 
 
As these questionnaires are a screening tool and not an in-depth assessment, the parent has been 
given feedback on the results and asked to contact you for continued monitoring of these 
developmental areas.  
 
Thank you for your participation in this research, 
Regards,  
Mindy Silva 
011 453-2624 
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18.7.3.2 Caregiver 
 
October 2, 2008      
 
Dear Parent(s),  
The forms that you have completed look carefully at how your baby is learning, developing and 
behaving. She is doing well in the areas below:  
 
 using hands and fingers to do things 
 listening and understanding 
 Using the larger muscles in her arms, legs and body 
 talking and speech 
  learning to take care of herself 
 getting along with others and behaving 
 
As this questionnaire is a screening tool and not a comprehensive assessment, we would advise you 
to make an appointment with your peadiatrician should there be anything that concerns you about 
your baby’s development. 
 
Because they have such a difficult start, developmental monitoring is especially important for a baby 
who has spent time in a NICU. The earlier difficulties are identified and addressed, the better their 
ability to overcome them and reach their full potential. Please ensure your child has regular 
developmental monitoring. 
If there are difficulties, good help is available.  
 
Please feel free to contact me at mindy@iburst.co.za or (011)453 2624 should you have any 
questions or concerns. 
 
Thank you,  
 
Mindy Silva 
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18.8 Other 
 
18.8.1 Kappa and Symmetry 
 
 
 
 
<http://www.dmi.columbia.edu/homepages/chuangj/kappa/ >  
[Accesed 26 June 2009] 
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 McNemar test  
 Symmetry. McNemar's test is sometimes called McNemar's test of symmetry or McNemar symmetry 
chi-square because it, and the marginal homogeneity test which extends it beyond dichotomous 
data, apply to square tables in which the diagonal reflects subjects who did not change between 
the before and after samples (or matched pair samples). The test variable may be nominal or 
ordinal. The test of symmetry tests whether the counts in cells above the diagonal differ from 
counts below the diagonal. If the two counts differ significantly, this reflects change between the 
samples, such as change due to an experimental effect between the before and after samples.  
 Computation of the McNemar Test. For the McNemar test, data are arranged as below (for 
convenience, cell letters have been added in red):     
  
 Note that you cannot have a simple table where the columns are "Time 1" and "Time 2", and the rows 
are "Exposed" and "Not Exposed", because then observations would appear twice in the table! 
 The McNemar test uses the chi-square distribution, based on this formula:   Chi-square = (|b - 
c| - 1)2)/(b + c) degrees-of-freedom = (rows - 1)(columns - 1) = 1 The formula above is the usual 
continuity-corrected version of the McNemar test. One occasionally encounters the uncorrected 
version, sometimes used for large samples, in which case the "-1" term in the numerator is 
omitted.  Example:   Chi-square = (|20 - 10| - 1)2)/(20 + 10) = 81/30 = 2.7 d.f. = (2 - 1)(2 - 1) = 
1   
 
< http://faculty.chass.ncsu.edu/garson/PA765/mcnemar.htm > [Accessed 25 Jan 2010] 
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Sample from statistical print out (Piet Becker, Biostatistics Unit, MRC) 
 
->  symmetry peds_sum asq_sum if (( 1 == peds_sum | peds_sum == 3) & ( 1 == 
asq_sum | asq_sum == 3) & ( 1 <= paed_sum & paed_sum <=  
> 3)& (visit ==1)) 
 
------------------------------- 
          |       asq_sum       
 peds_sum |   1      3    Total 
----------+-------------------- 
        1 |    8      0      8  
        3 |    1     13     14  
          |  
    Total |    9     13     22  
------------------------------- 
 
                                             chi2     df      Prob>chi2 
------------------------------------------------------------------------ 
Symmetry (asymptotic)                 |      1.00      1         0.3173 
Marginal homogeneity (Stuart-Maxwell) |      1.00      1         0.3173 
------------------------------------------------------------------------ 
 
->  kap peds_sum asq_sum if (( 1 == peds_sum | peds_sum == 3) & ( 1 == asq_sum | 
asq_sum == 3) & ( 1 <= paed_sum & paed_sum <= 3)& ( 
> visit ==1)) 
 
             Expected 
Agreement   Agreement     Kappa   Std. Err.         Z      Prob>Z 
----------------------------------------------------------------- 
  95.45%      52.48%     0.9043     0.2122       4.26      0.0000 
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18.8.2 Chronological Age Computation and Adjustment for Prematurity 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